Analysis of Clinical Guidelines

Gersende Georg, Centre des Cordeliers, UMRS 872 Eq. 20, Paris, France

Study of References using Tropes

The surface of the disease sphere is proportional to the number of words it contains. The graph shows the Relations between the References. The References on the left of the central Reference are its predecessors, those on the right its successors. The associated references for disease are: treatment, therapy, patient, diagnosis, indication.

The associated references for patient are: therapy, disease, treatment, therapy, indication.

The associated references for therapy are: disease, treatment, drug, indication.

The associated references for treatment are: disease, patient, therapy, indication, dose, and drug.

We first studied the frequency of deontic verbs for the set of clinical guidelines collected (composed of 44 892 word occurrences).

We used the statistical text analysis software Tropes^{TM [1]} to analyze these documents, particularly words occurrences and lemmatized verbs. We considered to recommend as the reference verb of the deontic modality in clinical guidelines due to the fact that in medical texts it always expresses recommendations.

The Star graph displays the Relations between References, or between a Word category and a Reference. The figures shown on the graphs give the number of Relations (co-occurrence frequency) existing between the various References. The graphs show the Relations between the References. They are oriented: the References on the left of the central Reference are its predecessors, those on the right its successors.

Co-occurrences of the verb to recommend are: therapy, indication, practitioner, information, patient, treatment, disease.

We studied the lexical context of each verb of the corpus and identified these which are similar to the reference verb. Co-occurrences of the verb shall are: disease, practitioner, patient, therapy, treatment, examination, assessment, dose, information.

Co-occurrences of the verb to use are: practitioner, decision, drug, disease, therapy, substance, patient, treatment, combination.

Co-occurrences of the verb to consider are: disease, therapy, practitioner, treatment, patient, examination, drug, diagnosis, agent.

We have a set of deontic verbs specific to clinical guidelines such as to recommend, shall, must, can, may. We also identified a set of associated deontic verbs such as to use, to consider to include to receive, to assess, to perform, to indicate, to treat, to associate, to associate, to reduce, to improve, to avoid, to begin, to prefer, to prescribe, to contraindicate.

We then studied the context of each deontic verb with the Simple Concordance Program[2] to determine patterns.

Examples of recommendations recognized by G-DEE[3]

Nurses embrace the following values and beliefs: respect; human dignity; clients are experts for their own lives; clients as leaders; clients' goals coordinate care of the healthcare team; continuity and consistency of care and caregiver; timeliness; responsiveness and universal access to care (1). These values and beliefs must be incorporated into, and demonstrated throughout , every aspect of client care and services (2).
The principles of client centred care should be included in the basic education of nurses in their core curriculum , be available as continuing education, be provided in orientation programs and be sustained through professional development opportunities in the organization (3). Organizations should engage all members of the healthcare team in this ongoing education process (4).
To foster client centred care consistently throughout an organization , healthcare services must be organized and administered in ways that ensure that all caregivers , regardless of their personal attributes , enact this practice successfully (5).
EEG should be used to support the classification of epileptic seizures and epilepsy syndromes when there is clinical doubt (6).
All infants born to mothers taking AEDs should be given vitamin K1 1 mg intramuscularly at birth (7).
For sustained control in other patients or if seizures continue, within 30 minutes (8). Give fosphenytoin in a dose of 18 mg/kg phenytoin equivalent (PE) IV, up to 150 mg/min with electrocardiography (ECG) monitoring; or phenytoin 18 mg/kg IV, 50 mg/min with ECG monitoring or phenobarbital 15 mg/kg IV, 100 mg/min (9). Rates of infusion may need to be reduced if hypotension or arrhythmia occur or in elderly or renal/ hepatic impairment (10).
Educate nurses, families, policy-makers, and the public to respond to expected or unexpected life events within the family (11).
Identify resources and supports to assist families address the life event, whether this is expected or unexpected (12). Resources should be identified within the following three categories (13). Intrafamilial Interfamilial Extrafamilial (14).
Assess family in the context of the event(s) to identify whether assistance is required by the nurse to strengthen and support the family (15). Surgeries performed with the intent to limit the venous outflow of the penis are not recommended (16).
Only vacuum constriction devices containing a vacuum limiter should be used whether purchased over-the-counter or procured with a prescription (17).
Arterial reconstructive surgery is a treatment option only in healthy individuals with recently acquired erectile dysfunction secondary to a focal arterial occlusion and in the absence of any evidence of generalized vascular disease (18).
If CIN is identified at the margins of a diagnostic excisional procedure or in a postprocedure endocervical sampling , it is preferred that the 4- to 6-month follow-up visit include a colposcopic examination and an endocervical sampling (19).
Excisional modalities are preferred for patients who have recurrent biopsy-confirmed CIN-1 after undergoing previous ablative therapy (20).
Podophyllin or podophyllin-related products are unacceptable for use in the vagina or on the cervix (21).
Colony-stimulating factors are not recommended for routine use to treat febrile or afebrile neutropenic patients (22).
Trimethoprim-sulfamethoxazole (TMP-SMZ) therapy is recommended at risk for Pneumocystis carinii pneumonitis , regardless of whether they have neutropenia (23).
If the patient becomes afebrile but remains neutropenic, the proper antibiotic course is less well defined (24). Some specialists recommend continuation of antibiotics , given intravenously or orally , until neutropenia is resolved (25).
Allergy to metronidazole is uncommon (26). Use 2% clindamycin cream for metronidazole allergic women (27).
The results of further randomised controlled trials of screening and treating all pregnant women are awaited, but there are insufficient data to make such a recommendation at present (28). In conclusion , symptomatic pregnant women should be treated in the usual way (29).
Management (30). General Advice (31). Ideally , treatment should be effective (microbiological cure rate >95%) , easy to take (not more than twice daily) , with a low side effect profile , and cause minimal interference with daily lifestyle (32).
If a speculum examination is not possible then urine samples can be utilized (33).
Fire hoses are sometimes found in hallways and stairwells of older facilities (34). Water from hoses is not sterile (35). The water can also create an electric shock hazard (36). In addition , the water stream itself can deliver sufficient force to cause injury or mechanical damage and can make the hose difficult to hold onto (37). The guideline developers do not recommend the uses of fire hoses to extinguish surgical fires (38).
Fire Drills (39). Fire drills not only allow staff to practice for a fire but also help troubleshoot any difficulties that might occur (40). Some elements to consider in planning a fire drill are (41). The proper response of each surgical team member and the operating suite staff (42). How the patient can easily and safely be moved to another OR How the spread of smoke should be prevented (for example , through the use of smoke doors and air duct dampers) (43). The location and operation of fire extinguishers, fire alarm pull stations, and exits (44). What the response of additional fire-fighting personnel (such as the fire response team and local fire department) should be (45).
If Evacuation is Necessary (46). In some very rare cases , extreme smoke and fire conditions may force the evacuation of the OR where the fire occurs (47). In such cases , the acronym RACE defines the actions that should take place (48).
In primary care and specialty medical settings , ACIP recommends implementation of standing orders to identify adults recommended for hepatitis B vaccination and administer vaccination as part of routine services (49). To ensure vaccination of adults at risk for HBV infection who have not completed the vaccine series , ACIP recommends the following implementation strategies (50). Provide information to all adults regarding the health benefits of hepatitis B vaccination , including risk factors for HBV infection and persons for whom vaccination is recommended (51). Help all adults assess their need for vaccination by obtaining a history that emphasizes risks for sexual transmission and percutaneous or mucosal exposure to blood (52). Vaccinate all adults who report risks for HBV infection (53). Vaccinate all adults requesting protection from HBV infection, without requiring them to acknowledge a specific risk factor (54).
Public health programs and primary care providers should adopt strategies appropriate for the practice setting to ensure that all adults at risk for HBV infection are offered hepatitis B vaccine (55).

Hepatitis B vaccination is recommended for all unvaccinated adults at risk for HBV infection and for all adults requesting protection from HBV infection (see Box below titled "Adults Recommended to Receive Hepatitis B Vaccination") (1). Acknowledgment of a specific risk factor should not be a requirement for vaccination (2).
A standing anteroposterior (AP) and a lateral view should be taken initially (3). A tangential view of the patella-femoral joint ("sunrise" view) and a standing posteroanterior (PA) view taken in 40 degrees of flexion can be useful (4).
Radiographic feature of OA include: narrowing of the cartilage space, marginal osteophytes, subchondral sclerosis, and beaking of the tibial spines (5).
Viscosupplementation may have a role in the treatment of knee pain due to osteoarthritis during the initial 12 weeks in the hands of physicians technically proficient in arthrocentesis (6).
Liver transplantation for metastatic neuroendocrine tumors should be confined to highly selected patients who are not candidates for surgical resection in whom symptoms have persisted despite optimal medical therapy (7).
Children with tyrosinemia who develop hepatocellular carcinoma (HCC) and meet the criteria for liver transplantation for HCC should be high-priority candidates (8).
Liver transplantation is the only effective treatment for infants with severe neonatal hemochromatosis (9). Urgent evaluation at a transplant center is recommended (10).
Recommendations for Diagnosis of Patients with an Intermediate Likelihood of Coronary Artery Disease (CAD) Exercise myocardial perfusion SPECT to assess the functional significance of intermediate (25 to 75%) coronary lesions (11).
Adenosine or dipyridamole myocardial perfusion SPECT after initial perfusion imaging in patients whose symptoms have changed to redefine the risk for cardiac event (12).
Identification of hemodynamic significance of coronary stenosis after coronary arteriography (13). Stress MPI (14).
Patients 6 years of age or older should be referred to an emergency department if they have ingested at least 10 g or 200 mg/kg (whichever is lower) or when the amount ingested is unknown (15).
Patients less than 6 years of age should be referred to an emergency department if the estimated acute ingestion amount is unknown or is 200 mg/kg or more (16). Patients can be observed at home if the dose ingested is less than 200 mg/kg (17).
Activated charcoal can be considered if local poison center policies support its prehospital use , a toxic dose of acetaminophen has been taken , and fewer than 2 hours have elapsed since the ingestion (18). Women at Average Risk (19). Begin mammography at age 40 (20).
For women in their 20s and 30s , it is recommended that clinical breast examination (CBE) be part of a periodic health examination , preferably at least every three years (21). Asymptomatic women aged 40 and over should continue to receive a clinical breast examination as part of a periodic health examination , preferably annually (22).
Beginning in their 20s , women should be told about the benefits and limitations of breast self-examination (BSE) (23).
Narcotic use must be carefully titrated and supervised (24).
Antibiotic prophylaxis is effective in reducing wound infection after hip fracture surgery (25).
Routine use of temporary leg traction appears to be unnecessary (26).
Analgesia/symptomatic treatment (27). Recognize that a number of morbidities commonly seen in homeless patients , including untreated dental problems , hepatitis , and traumatic injuries , can result in chronic pain (28). It is important to remember that some drugs , such as methadone and other narcotics , can increase or decrease the effects of pain medications (29). Work with the patient to understand the underlying cause of pain (30). Prescribe appropriate pain medication and document why you prescribed it (31).
To avoid overmedicating or contributing to drug-seeking behavior, specify the plan of care in a written contract with the patient, designating a single provider for pain prescription refills (32). Consider providing a cough suppressant or analgesia for a children acute ear infection, if not detrimental, to allow the child to sleep (33). A crying child will disrupt other shelter residents , which could place the family at risk for eviction (34).
If so, consult the Association of Occupational and Environmental Clinics for referrals and assistance (35).
A written action plan can give the patient and/or parent a sense of control (36). Most important is to clarify the plan of care in language they can understand (37). For those who are comfortable with written information , summarize key points on a pocket card that can be carried with them (38). Ask if there is another person who can help the patient or family cope with illness (39).
Drug treatment with peginterferon alfa-2a or adefovir dipivoxil should be initiated only by an appropriately qualified healthcare professional with expertise in the management of viral hepatitis (40). Continuation of therapy under shared-care arrangements with a general practitioner is appropriate (41).
Adefovir dipivoxil should not normally be given before treatment with lamivudine (42). It may be used either alone or in combination with lamivudine when treatment with lamivudine has resulted in viral resistance , or lamivudine resistance is likely to occur rapidly (for example , in the presence of highly replicative hepatitis B disease) , and development of lamivudine resistance is likely to have an adverse outcome (for example , if a flare of the infection is likely to precipitate decompensated liver disease) (43).
Peginterferon alfa-2a is recommended as an option for the initial treatment of adults with chronic hepatitis B (HBeAg-positive or HBeAg-negative) , within its licensed indications (44).
When assessing adherence , clinicians should use precise language that the patient can understand (45). In addition , clinicians should verify that patients are taking the medications as prescribed , specifically , correct medications , correct number of pills per dose , and correct number of doses per day (46).
Clinicians should reassess potential barriers to adherence at least every 3 to 4 months and whenever adherence problems are identified (47).
Clinicians should assess potential interactions between HAART and methadone before and during therapy by inquiring about oversedation and opioid withdrawal symptoms (48). If withdrawal symptoms are present , the primary care clinician should conduct a detailed history and facilitate a dose increase by educating the patient and communicating with the methadone provider (49). The stage of ovarian cancer is an important prognostic factor that influences survival and the choice of therapy (50). The quality of the surgical staging is a key determinant of treatment recommendations (51).
Women who have not undergone optimal surgical staging can be offered two options (52). The first option is that they undergo reoperation to optimally define the tumour stage and then be offered adjuvant therapy based on the findings (53). The other option is that they be offered platinum-based chemotherapy to decrease the risk of recurrence and improve survival (54).
There is insufficient evidence to make a recommendation on the role of adjuvant pelvic radiation, whole abdominal-pelvic radiotherapy, or intraperitoneal radioactive chromic phosphate (55).
There is insufficient evidence to reliably inform the use of intracavitary radiotherapy either alone or in combination with external beam radiotherapy (56).
Regardless of surgical staging, adjuvant external beam radiotherapy is recommended for patients at high risk of recurrence is not recommended in patients at low risk of recurrence is a reasonable treatment option for patients at intermediate risk of recurrence Two randomized trials detected that adjuvant external beam radiotherapy improved pelvic control, but not survival, when compared to no further treatment (57). In patients with no adjuvant therapy , salvage radiotherapy may be effective upon vaginal recurrence (58). When considering adjuvant radiotherapy, the potential improvement in pelvic control needs to be weighed against the toxicity of radiotherapy (59). Radiotherapy was associated with a low incidence of severe acute and late adverse effects; however, many patients experienced mild (grade 1 or 2) side effects (60). The long-term effects of radiotherapy are unknown at this time (61).
With the potential for substantial grade changes upon pathology review , which may influence decisions regarding adjuvant radiotherapy , it may be important for each jurisdiction to establish a level of quality assurance with specific indications for pathology review (62). However , the extent to which quality assurance can be determined is outside of the scope of this report (63).
Specialized nutrition support (SNS) should be used in patients who cannot meet their nutrient requirements by oral intake (64).
When SNS is required , enteral nutrition (EN) should generally be used in preference to parenteral nutrition (PN) (65). Help ensure that all adolescents have knowledge of and access to contraception including barrier methods and emergency contraception supplies (66).
Be aware of options and resources for adolescents and advocate for comprehensive medical and psychosocial support for all pregnant adolescents in the community (67).
Assess the adolescent mother's abilities to care for her children and have resources available for referral and assistance before neonatal discharge (68).
Nurses working with individuals with asthma must have the appropriate knowledge and skills to (69). Identify the level of asthma control,Provide basic asthma education,Conduct appropriate referrals to physician and community resources (70).
Education should include as a minimum , the following (71). Basic facts about asthma,Roles/rationale for medications,Device technique(s),Self-monitoring,Action plans (72).
Clients with poorly controlled asthma should be referred to their physician (73).
In choosing the components for a clinically relevant vaccine , the physician should be familiar with local and regional aerobiology and indoor and outdoor allergens , paying special attention to potential allergens in the patient's own environment (74).
Summary Statement 55 (75). In older adults , medications and co-morbid medical conditions may increase the risk from immunotherapy (76). Therefore , special consideration must be given to the benefits and risks of immunotherapy in older adults (77).
The maintenance concentrate and serial dilutions , whether a single vaccine or a mixture of vaccines , should be prepared and labeled for each patient (78).
There is evidence from one randomized controlled trial demonstrating that continuous hyperfractionated accelerated radiation therapy (CHART) improves survival over standard radiotherapy of 60 Gy in 30 fractions, in patients with locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) (79). Selected patients (with Eastern Cooperative Oncology Group [ECOG] performance status > 1 who do not fit the criteria for induction chemotherapy and radiotherapy or patients who prefer radiotherapy only) may be considered for continuous hyperfractionated accelerated radiation therapy (80).
GH treatment is indicated in children with documented GHD for correction of hypoglycemia and for induction of normal statural growth (81).
GH treatment is indicated for girls with Turner syndrome (82).
GH therapy is best accomplished under the direct supervision of a clinical endocrinologist (83). Short-term GH treatment is safe in both children and adults (84). Continued monitoring of side effects and long-term treatment results is needed (85).
Numerous observations are compatible with androgen therapy yielding improved bone-related factors, particularly in doses that exceed the normal range (86).
Adverse effects may occur with androgen replacement therapy at supraphysiologic levels (87). Acne, hirsutism, and a significant reduction in high-density lipoprotein (HDL) cholesterol levels have been described (88).
Each patient should be appropriately monitored with use of dual-energy x-ray absorptiometry as well as known clinical factors of fracture risk to determine the adequacy of an administered dose of estrogen (89).
Similar results have been noted in the treatment of cardiac and peripheral vascular ischemic disease (90).
Saw Palmetto (91). Only two strong studies support the use of saw palmetto extract in patients with benign prostatic hypertrophy (92).
Clinical toxicities related to the use of this product seem to be minimal (93). Therefore , with conclusive level 2 data available , saw palmetto extract may be recommended for patients with benign prostatic hypertrophy who refuse conventional therapy or in whom conventional therapy fails (94).
Glutamine (95). Glutamine is a nontoxic, physiologically important agent that is beneficial in critical illness (96).
Cervical cancer screening should begin approximately three years after the onset of vaginal intercourse (97). Screening should begin no later than 21 years of age (98).
Screening with vaginal cytology tests following total hysterectomy (with removal of the cervix) for benign gynecologic disease is not indicated (99). Efforts should be made to confirm and/or document via physical exam and review of the pathology report (when available) that the hysterectomy was performed for benign reasons (the presence of cervical intraepithelial neoplasia (CIN) 2/3 is not considered benign) and that the cervix was completely removed (100).
A selective estrogen receptor modulator (SERM) has been approved by the FDA for the prevention and treatment of osteoporosis in menopausal women (101). A bone disease specialist should participate in the decision to choose a SERM in patients with GI diseases (102).
There is insufficient evidence to support a role for IV bisphosphonates as an adjunctive therapy to radiation therapy in women with pain caused by metastatic bone disease when systemic chemotherapy and/or hormonal therapy is not being used (103). The role of bisphosphonates vis-a-vis radiation therapy as the sole therapy in this setting has not been determined (104). In women already being treated with local radiotherapy who have persistent or recurrent pain, bisphosphonates are an attractive but little-studied salvage therapy (105).
The Panel suggests that, once initiated, IV bisphosphonates be continued until evidence of substantial decline in a patient's general performance status (106). The Panel stresses that clinical judgment must guide what is a substantial decline (107). There is no evidence addressing the consequences of stopping bisphosphonates after one or more adverse skeletal-related events (SREs) (108).
Starting bisphosphonates in women without evidence of bone metastases , even in the presence of other extraskeletal metastases , is not recommended (109). This clinical situation has not been studied using IV bisphosphonates and should be the focus of new clinical trials (110).
Regular gynecologic follow-up is recommended for all women (111). Patients who receive tamoxifen therapy are at increased risk for developing endometrial cancer and should be advised to report any vaginal bleeding to their physicians (112). Longer follow-up intervals may be appropriate for women who have had a total hysterectomy and oophorectomy (113).
[18F]fluorodeoxyglucose-positron emission tomography (FDG-PET) scanning is not recommended for routine breast cancer surveillance (114).
Computed Tomography (CT) (115). Recommendation (116). CT is not recommended for routine breast cancer surveillance (117).
Bilateral orchiectomy or medical castration with luteinizing hormone releasing hormone (LHRH) agonists are the recommended initial treatments for metastatic prostate cancer (118).
A full discussion between practitioner and patient should occur to determine which is best for the patient (119).
A discussion should occur between the patient and his practitioner (120). The patient needs to appreciate that there is a small potential gain in overall survival (OS) with the addition of a nonsteroidal antiandrogen to medical or surgical castration and that increased side effects may occur as a result (121).
Until data from studies using modern medical diagnostic and biochemical tests and standardized follow-up schedules become available , no specific recommendations can be issued by the Panel regarding the question of early versus deferred ADT using LHRH agonists or orchiectomy (122). A discussion about the pros and cons of early versus deferred therapy should occur between patient and practitioner (123).
Antiandrogen monotherapy is not recommended (124). Patients should be followed clinically and started on ADT once symptoms of locally progressive or metastatic disease present (125).
Staging Distant Metastatic Disease (126). Adrenal (127). The finding of an isolated adrenal mass on ultrasonography, CT scan, or FDG-PET scan requires biopsy to rule out metastatic disease if the patient is otherwise considered to be potentially resectable (128).
Treatment (129). Radiotherapy (130). Local- and Distant-Site Palliative Effects of External-Beam Radiation (131).
Diagnostic Evaluation of Patients with Advanced Lung Cancer (132). Staging Locoregional Disease (133). Negative FDG-PET scanning does not preclude biopsy of radiographically enlarged mediastinal lymph nodes (134).
The Task Force recommends the following endpoints be considered for safety and risk assessment in future studies (135). Appearance of or change in hirsutism, acne, male pattern balding, clitoromegaly, and deepening of the voice (136). Cardiovascular and metabolic evaluation , with and without estrogen replacement , should include fasting lipid profiles , vascular reactivity , markers of insulin sensitivity , and markers of inflammation (137). Effects on the breast , with or without estrogen replacement , should be measured (138). Breast biopsy studies with in vitro markers of cell proliferation and apoptosis should be considered (139).
Alterations in the endometrium with and without estrogen coadministration Alterations in mood using validated instruments (140).
The Task Force recommends further study of physiologic targets of androgen action such as (141). Sexual dysfunction Cognition Mood Bone Cardiovascular function Body composition Muscle strength and function (142).
The Task Force recommends additional research in the following human model systems to define the clinical syndrome of androgen deficiency and to study the benefits and risks of androgen therapy (143). Surgical menopause is a condition in which the ovarian, but not adrenal androgen precursors are removed abruptly independent of age (144). Hypopituitarism , although uncommon , can be used to study the physiological replacement of both ovarian androgens and adrenal androgen precursors (145). Anorexia nervosa may be used as a model of androgen deficiency secondary to dysfunction of the hypothalamic-pituitary and adrenal axes (146).
Primary adrenal insufficiency allows for the investigation of the loss of adrenal androgen precursors in the presence of intact ovarian androgen function (147). Ablation-replacement models in normal women using GnRH analogs to eliminate ovarian androgens, with or without suppression of adrenal androgen precursors, offer another way to assess the effects of androgen withdrawal and replacement (148). Subjects with complete androgen insensitivity syndrome offer a way to investigate target tissue effects which are dependent on the androgen receptor but are independent of aromatization (149).
In patients whose cough resolves after the cessation of therapy with ACE inhibitors , and for whom there is a compelling reason to treat with these agents , a repeat trial of ACE inhibitor therapy may be attempted (150).
In patients for whom the cessation of ACE inhibitor therapy is not an option , pharmacologic therapy , including that with sodium cromoglycate , theophylline , sulindac , indomethacin , amlodipine , nifedipine , ferrous sulfate , and picotamide that is aimed at suppressing cough should be attempted (151).
The optimal treatment-delivery interval for administration of antenatal corticosteroids is more than 24 hours but fewer than seven days after the start of treatment (152).
Obstetricians should consider enrolling their patients in randomised controlled trials if repeat corticosteroid therapy is contemplated (153).
In patients with stroke associated with aortic atherosclerotic lesions , the guideline developers recommend antiplatelet therapy over no therapy (154). For patients with cryptogenic stroke associated with mobile aortic arch thrombi, the guideline developers suggest either oral anticoagulation or antiplatelet agents (155).
For acute stroke patients with restricted mobility , the guideline developers recommend prophylactic low-dose subcutaneous heparin or low molecular weight heparins or heparinoids (156).
For patients with AF and prosthetic heart valves , the guideline developers recommend anticoagulation with an oral VKA , such as warfarin (157).
For AF occurring shortly after open-heart surgery and lasting >48 hours, the guideline developers suggest anticoagulation with an oral VKA, such as warfarin, if bleeding risks are acceptable (Grade 2C) (158).
In patients with persistent AF or PAF , age 65 to 75 years , in the absence of other risk factors , the guideline developers recommend antithrombotic therapy (159).
For patients undergoing CABG who have no other indication for vitamin K antagonists (VKAs), the guideline developers suggest clinicians not administer VKAs (160).
For all patients undergoing IMA bypass grafting who have no other indication for VKAs, the guideline developers suggest clinicians not use VKAs (161).
For all patients with coronary artery disease who undergo internal mammary artery (IMA) bypass grafting , the guideline developers recommend aspirin , 75 to 162 mg/day , indefinitely (162).
Treatments for Different Types of Anxiety Disorders (163). Cognitive behaviour therapy (CBT) is the psychotherapy of choice for panic disorder (164). Possible treatment components for panic disorder, with or without agoraphobia, are Psychoeducation (165). Exposure to symptoms or situations Cognitive restructuring Breathing retraining Continuous panic monitoring (166).
Treatment Settings for Anxiety Disorders (167). Psychiatric evaluation and treatment is appropriate when (168). There is serious risk of suicide (169). There are psychotic symptoms (170). Cooccurring drug/alcohol problems exist (171). Symptoms are severe/complex (172). If symptoms fail to improve on initial treatment and follow-up (173).
Psychosocial Interventions for Anxiety Disorders (174). Psychological therapy should be routinely considered as a treatment option when assessing mental health problems , including anxiety disorder (175).
Parents should be advised that home cardiorespiratory monitoring has not been proven to prevent sudden unexpected deaths in infants (176).
Home cardiorespiratory monitoring may be warranted for premature infants who are at high risk of recurrent episodes of apnea , bradycardia , and hypoxemia after hospital discharge (177). The use of home cardiorespiratory monitoring in this population should be limited to approximately 43 weeks postmenstrual age or after the cessation of extreme episodes , whichever comes last (178).
Home cardiorespiratory monitoring should not be prescribed to prevent sudden infant death syndrome (SIDS) (179).
None of the three markers TS , DPD , or TP are recommended for use to determine the prognosis of colorectal carcinoma (180).
Surveillance colonoscopy with multiple biopsy specimens should be performed every 1 to 2 years beginning after 8 to 10 years of disease (181).
Genetic testing along with counseling is recommended for individuals with hereditary forms of CRC , including familial adenomatous polyposis (FAP) and hereditary nonpolyposis colon cancer (HNPCC) (182).
Alternative methods for CRC screening in average-risk patients include yearly fecal occult blood testing (A), flexible sigmoidoscopy every 5 years, combined yearly fecal occult blood testing (FOBT) and flexible sigmoidoscopy every 5 years (183).
Although an increased cancer risk has not been established in patients with Barrett's esophagus and low-grade dysplasia , endoscopy at 6 months and yearly thereafter should be considered (184).
Postgastric Surgery (185). There are insufficient data to support routine endoscopic surveillance for patients with previous partial gastrectomy for peptic ulcer disease (186).
Polypoid defects of any size detected radiographically should be evaluated endoscopically , with biopsy and/or removal of the lesions (187).
Substance users who wish to stop using drugs should be referred to substance abuse treatment when indicated (188).
The drug regimen of choice is currently unknown because no randomized comparative trials have been conducted in this patient population (189). Options include tenofovir , emtricitabine , interferon alfa-2b , lamivudine , or adefovir; there are insufficient data to recommend combinations of drugs at this time (190). If lamivudine is given for treatment of hepatitis B , it should never be used alone but in combination with other HIV-active antiretroviral agents as a component of highly active antiretroviral therapy (HAART) (191).
Clinicians should inform and advise HIV-infected substance users chronically infected with hepatitis B (or co-infected with hepatitis B and C) that sharing injection equipment and engaging in unprotected sex place their partners at risk for transmission of both HIV and viral hepatitis (192).
Foot Ulcer Assessment (193). Describe and document the ulcer characteristics (194).
Practice Recommendations (195). Patient Empowerment and Education (196). Education is based on identified individual needs, risk factors, ulcer status, available resources, and ability to heal (197).
Management (198). Provide pressure redistribution (199).
Practice settings need a policy with respect to providing and requesting advance notice when transferring or admitting clients between practice settings when special resources (e.g., surfaces) are required.
Reassess ulcers at least weekly to determine the adequacy of the treatment plan (200).
Medical management may include initiating a two-week trial of topical antibiotics for clean pressure ulcers that are not healing or are continuing to produce exudate after two to four weeks of optimal patient care (201). The antibiotic should be effective against gram-negative , gram-positive and anaerobic organisms (202).
Carers (203). Older people who are carers of people with intellectual or other disabilities should be assessed for health and support needs (204).
Assessors and Multidisciplinary Teams. (205). Assessors of older people should be part of (or have ready access to) a wider multidisciplinary team (MDT) to whom they can quickly refer the older person for more in-depth assessment or for help in any particular domain (206).
Location of Assessment (207). Proactive assessments of people should usually take place within the older persons home , unless the older person is in an emergency department (ED) (208). Attendance at an ED should trigger a comprehensive assessment prior to discharge (209).
Asthma should be considered well controlled if (1) asthma symptoms are twice a week or less; (2) rescue bronchodilator medication is used twice a week or less; (3) there is no nocturnal or early morning awaking; (4) there are no limitations of work , school , or exercise; (5) the patient and physician consider their asthma well controlled; and (6) the patient's peak expiratory flow (PEF) or forced expiratory volume in one second (FEV1) is normal or his or her personal best (210).
A patient's asthma control for a specific clinical encounter should be determined as well controlled or not well controlled (211). Asthma symptoms do not always correlate with asthma severity (212). There are limitations to classifying asthma severity in patients already being treated (213).
Premature ejaculation can be treated effectively with several serotonin reuptake inhibitors (SRIs) or with topical anesthetics (214). The optimal treatment choice should be based on both physician judgment and patient preference (215).
The diagnosis of premature ejaculation (PE) is based on sexual history alone (216). A detailed sexual history should be obtained from all patients with ejaculatory complaints (217).
The risks and benefits of all treatment options should be discussed with the patient prior to any intervention (218). Patient and partner satisfaction is the primary target outcome for the treatment of PE (219).
In women with pathological stage III tumours , bone scanning , liver ultrasonography , and chest radiography are recommended postoperatively as part of baseline staging (220).
In women for whom treatment options are restricted to tamoxifen or hormone therapy , or for whom no further treatment is indicated because of age or other factors , routine bone scanning , liver ultrasonography , and chest radiography are not indicated as part of baseline staging (221).
In women who have pathological stage II tumours , a postoperative bone scan is recommended as part of baseline staging (222).
Routine liver ultrasonography and chest radiography are not indicated in this group but could be considered for patients with four or more positive lymph nodes (223).
Ambulance transportation is recommended for patients who are referred to emergency departments because of the potential for life-threatening complications of beta-blocker overdose (224). Provide usual supportive care en route to the hospital, including intravenous fluids for hypotension (225).
Asymptomatic patients who are referred to healthcare facilities should be monitored for at least 6 hours after ingestion if they took an immediate-release preparation other than sotalol , 8 hours if they took a sustained-release preparation , and 12 hours if they took sotalol (226). Routine 24-hour admission of an asymptomatic patient who has unintentionally ingested a sustained-release preparation is not warranted (227).
Patients with stated or suspected self-harm or who are the victims of a potentially malicious administration of beta-blocker should be referred to an emergency department immediately (228). This referral should be guided by local poison center procedures (229). In general , this should occur regardless of the dose reported (230).
Women with early stage (stages I and II) breast cancer who have undergone breast conservation surgery should be offered postoperative breast irradiation (231).
The optimal fractionation schedule for breast irradiation has not been established and the role of boost irradiation is unclear (232). Outside of a clinical trial, two commonly used fractionation schedules are suggested (233).
Women who have undergone breast conservation surgery should receive local breast irradiation as soon as possible following wound healing (234). A safe interval between surgery and the start of radiotherapy is unknown, but it is reasonable to start breast irradiation within 12 weeks of definitive surgery (235).
Evaluation of education programs should be considered in order to evaluate the effectiveness of prenatal breastfeeding classes (236).
Nurses with experience and expertise in breastfeeding should provide support to mothers (237). Such support should be established in the antenatal period , continued into the postpartum period and should involve face-to-face contact (238).
Key components of the prenatal assessment should include (239).
If docetaxel and capecitabine are used in combination , the recommended starting dose for most patients is 950 mg/m2 twice daily of capecitabine (75% of full dose) on days 1 to 14 plus docetaxel 75 mg/m2 intravenously on day 1 of a 21-day cycle (240).
In patients with renal impairment , capecitabine therapy can increase systemic exposure to alpha-fluoro-beta-alanine (FBAL) and 5-deoxy-5-fluorouridine (5- DFUR) (241).
All schools should implement age-appropriate and culturally sensitive curricula on changing students' patterns of dietary intake , physical activity , and smoking behaviors (242).
All schools should institute policies that they be maintained as tobacco-free environments (243).
School policies should address all foods and snacks consumed on- and off-premises during school hours (244).
Nurses will change all add-on devices a minimum of every 72 hours (245).
Nurses will assess and evaluate vascular access devices for occlusion in order to facilitate treatment and improve client outcomes (246).
Health care organizations have access to infusion therapy nursing expertise to support optimal vascular access outcomes (247).
Although the available evidence suggests a lower VAP rate with passive humidification than with active humidification, other issues related to the use of passive humidifiers (resistance, dead space volume, airway occlusion risk) preclude a recommendation for the general use of these devices (248). The decision to use a passive humidifier should not be based solely on infection control considerations (249).
Evidence is lacking related to ventilator-associated pneumonia (VAP) and issues of heated versus unheated circuits, type of heated humidifier, method for filling the humidifier, and technique for clearing condensate from the ventilator circuit (250). It is prudent to avoid excessive accumulation of condensate in the circuit (251). Care should be taken to avoid accidental drainage of condensate into the patient airway and to avoid contamination of caregivers during ventilator disconnection or during disposal of condensate (252). Care should be taken to avoid breaking the ventilator circuit , whic could contaminate the interior of the circuit (253).
Women with uncomplicated (extended or flexed leg) breech presentation at term should be offered a caesarean after full discussion of the risks and benefits (254).
Women with uncomplicated breech at 37 to 40 weeks should be offered external cephalic version (ECV) to increase the likelihood of cephalic presentation and vaginal birth (255).
Full and unbiased information on choosing VBAC should be discussed on a case-by-case basis with the pregnant woman with previous caesarean to enable her to make an informed decision about her birth choices (256).
Clinicians should consider patient variables in CE decision making (257). Clinicians should also consider several radiologic factors in decision making about CE (258).
Carotid endarterectomy (CE) is established as effective for recently symptomatic (within previous 6 months) patients with 70 to 99% internal carotid artery (ICA) angiographic stenosis (259). CE should not be considered for symptomatic patients with less than 50% stenosis (260). CE may be considered for patients with 50 to 69% symptomatic stenosis but the clinician should consider additional clinical and angiographic variables (261). It is recommended that the patient have at least a 5-year life expectancy (262).
The panel recommends the following (263). Formation of a federation of celiac disease societies, celiac disease interest groups, individuals with celiac disease and their families, physicians, dietitians, and other health care providers for the advancement of education, research, and advocacy for individuals with celiac disease (264).
To reduce the incidence and mortality rate of cervix cancer , effective screening and preventive strategy must be actively pursued in addition to early detection of disease and effective therapy (265).
Ovarian conservation should be considered for young patients (266).
The addition of post-operative treatment using a combination of chemotherapy and radiotherapy has been shown to improve survival outcome for patients with tumour involvement of pelvic lymph nodes, resection margins, and/or parametrial tissue (267).
Combination platinum-based chemotherapy can be administered safely and with acceptable and manageable toxicity profiles in patients with good PS who have stage IV NSCLC (268).
When selecting patients for systemic chemotherapy , performance status (PS) at the time of diagnosis should be used because it is a consistent prognostic factor for survival (269). Patients with a PS of Eastern Cooperative Oncology Group (ECOG) 0 or 1 should be offered chemotherapy (270). Data are not yet sufficient to routinely recommend chemotherapy to patients with a PS of ECOG level 2 (271). Patients with a PS of ECOG level 3 or 4 should not receive chemotherapy (272).
If survival is the main outcome of interest for a patient, it is reasonable to offer chemotherapy to medically suitable patients as an option for this condition with a full discussion of the benefits, limitations, and toxicities (273). If symptom control and/or quality of life are the outcomes of interest for a patient , chemotherapy is a reasonable option which may improve quality of life and reduce disease-related symptoms (274).
Strong evidence including meta-analyses indicates that there is a small survival benefit of cisplatin-based chemotherapy over best supportive care in patients with non-small cell lung cancer and good performance status (275).
Testing may also be performed to reassure the patient , parent , and physician of the absence of organic disease , particularly if the pain significantly diminishes the quality of life of the patient (276).
Functional abdominal pain generally can be diagnosed correctly by the primary care clinician in children 4 to 18 years of age with chronic abdominal pain when there are no alarm symptoms or signs , the physical examination is normal , and the stool sample tests are negative for occult blood , without the requirement of additional diagnostic evaluation (277).
Education of the family is an important part of treatment of the child with functional abdominal pain (278). It is often helpful to summarize the child's symptoms and explain in simple language that although the pain is real, there is most likely no underlying serious or chronic disease (279). It may be helpful to explain that chronic abdominal pain is a common symptom in children and adolescents , yet few have a disease (280). Functional abdominal pain can be likened to a headache , a functional disorder experienced at some time by most adults , which very rarely is associated with serious disease (281).
In a patient with an acute respiratory infection manifested predominantly by cough , with or without sputum production , lasting no more than 3 weeks , a diagnosis of acute bronchitis should not be made unless there is no clinical or radiographic evidence of pneumonia and the common cold , acute asthma , or an exacerbation of chronic obstructive pulmonary disease (COPD) have been ruled out as the cause of cough (282).
In a patient with chronic cough , asthma should always be considered as a potential etiology because asthma is a common condition with which cough is commonly associated (283).
Patients with severe and/or refractory cough due to asthma should receive a short course (1 to 2 weeks) of systemic (oral) corticosteroids followed by inhaled corticosteroids (284).
For patients with asthmatic cough that is refractory to treatment with inhaled corticosteroids and bronchodilators , in whom poor compliance or another contributing condition has been excluded , an leukotriene receptor antagonist (LTRA) may be added to the therapeutic regimen before the escalation of therapy to systemic corticosteroids (285).
In patients with cough secondary to sarcoidosis , therapy with oral corticosteroids followed by inhaled corticosteroids may improve symptoms (286).
In patients with cough secondary to sarcoidosis , although therapy with oral corticosteroids may lead to symptomatic improvement , as they have not been proven to have a durable benefit and are associated with significant side effects , an individualized analysis of the overall benefit and risk is necessary (287).
In patients with chronic cough , before diagnosing interstitial lung disease (ILD) as the sole cause , common etiologies such as upper airway cough syndrome (UACS) , which was previously referred to as postnasal drip syndrome , asthma , and gastroesophageal reflux disease (GERD) should be considered (288). As these common causes may also share clinical features with specific ILDs , a diagnosis of ILD as the cause of cough should be considered a diagnosis of exclusion (289).
For patients with more advanced NSCLC (stages III and IV) , external beam radiation and/or chemotherapy should usually be offered (290).
For patients with cough and lung cancer , the use of centrally acting cough suppressants such as dihydrocodeine and hydrocodone is recommended (291).
In patients with a suspicion of airway involvement by a malignancy (e.g., smokers with hemoptysis), even when the chest radiograph findings are normal, bronchoscopy is indicated.
In patients with chronic cough due to nonasthmatic eosinophilic bronchitis, the possibility of an occupation-related cause needs to be considered (292).
For patients with chronic cough due to nonasthmatic eosinophilic bronchitis, the first-line treatment is inhaled corticosteroids (except when a causal allergen or sensitizer is identified (293).
In patients with chronic cough with normal chest radiograph findings, normal spirometry findings, and no evidence of variable airflow obstruction or airway hyperresponsiveness, the diagnosis of nonasthmatic eosinophilic bronchitis as the cause of the chronic cough is confirmed by the presence of an airway eosinophilia, either by sputum induction or bronchial wash fluid obtained by bronchoscopy, and an improvement in the cough following corticosteroid therapy (294).
In patients with cough and incomplete or irreversible airflow limitation , direct or indirect signs of small airways disease seen on high resolution computed tomography (HRCT) scan , or purulent secretions seen on bronchoscopy , nonbronchiectatic suppurative airways disease (bronchiolitis) should be suspected as the primary cause (295).
In patients with cough in whom more common causes have been excluded , because bacterial suppurative airways disease may be present and clinically unsuspected , bronchoscopy is required before excluding it as a cause (296).
In patients with DPB , prolonged treatment (> 2 to 6 months) with erythromycin (or other 14-member ring macrolides such as clarithromycin and roxithromycin) is recommended (297).
In patients with chronic cough who live in areas with a high prevalence of TB , this diagnosis should be considered , but not to the exclusion of the more common etiologies (298). Sputum smears and cultures for acid fast bacilli and a chest radiograph should be obtained whenever possible (299).
In patients with unexplained chronic cough who have resided in areas of endemic infection with fungi or parasites , a diagnostic evaluation for these pathogens should be undertaken when more common causes of cough have been ruled out (300).
In areas where there is a high prevalence of tuberculosis (TB) , chronic cough should be defined as it is in the World Health Organization Practical Approach to Lung Health (PAL) program as being 2 to 3 weeks in duration (301).
Serological screening for hepatitis B surface (HBs) antigen and antibody (HBs Ag , anti-HBs IgG) should be done within 6 months pre-vaccination for all , except newborns (302).
Patients should be told of the risks of hepatocellular carcinoma (HCC) associated with chronic hepatitis B infection and offered the option of hepatocellular carcinoma surveillance (303). For patients who are agreeable to surveillance , ultrasonography and serum alpha-fetoprotein should be done at regular intervals (304). Ultrasonography should be done at 6- and 12-monthly intervals for cirrhotic and non-cirrhotic patients , respectively (305). Patients' blood should be sampled for alpha-fetoprotein every 3 to 6 months and 6 to 12 months for cirrhotic and non-cirrhotic patients , respectively (306).
Patients with normal serum alanine transaminase (ALT) levels should have 6-monthly outpatient follow-up visits with repeat serum ALT done at each visit (307). Patients with elevated serum ALT levels should have more frequent follow-up visits , with repeat liver function tests carried out based on the physician-in-charge's discretion (308).
In patients for whom a specific etiology of chronic cough is not apparent , empiric therapy for UACS in the form of a first generation A/D preparation should be prescribed before beginning an extensive diagnostic workup (309).
A patient suspected of having UACS induced cough who does not respond to empiric antihistamine/decongestant (A/D) therapy with a first-generation antihistamine should next undergo sinus imaging (310).
In patients in whom the cause of the UACS-induced cough is apparent , specific therapy directed at this condition should be instituted (311).
Confirm that the infant has a scheduled appointment with a primary care provider or health worker within five to seven days after birth (312). Schedule additional visits as needed until a consistent weight gain pattern has been established (III).Identify breastfeeding support resources within the community such as. International Board Certified Lactation Consultants (IBCLCs) Community health workers and home visitors trained to provide breastfeeding support Breastfeeding clinic staff Health department staff (313).
Comply with the International Code of Marketing of Breast-milk Substitutes and subsequent World Health Assembly resolutions, and avoid distribution of infant feeding product samples and advertisements for such products (314).
Identify maternal and infant risk factors that may impact the mother's or infant's ability to breastfeed effectively and provide appropriate assistance and follow-up (315).
Females aged between 1 and 2 years presenting with fever without source should be considered at risk for having a urinary tract infection (316).
Obtain a urine culture in conjunction with other urine studies when urinary tract infection is suspected in a child aged younger than 2 years because a negative urine dipstick or urinalysis result in a febrile child does not always exclude urinary tract infection (317).
Urethral catheterization or suprapubic aspiration are the best methods for diagnosing urinary tract infection (318).
For patients receiving neuromuscular blocking agents and corticosteroids , every effort should be made to discontinue neuromuscular blocking agents as soon as possible (319).
Institutions should perform an economic analysis using their own data when choosing neuromuscular blocking agents for use in an intensive care unit (320).
Drug holidays (i.e., stopping neuromuscular blocking agents daily until forced to restart them based on the patients condition) may decrease the incidence of acute quadriplegic myopathy syndrome (AQMS).
If blood pressure measurements are persistently elevated with a systolic blood pressure greater than 140 mm Hg or diastolic blood pressure greater than 90 mm Hg , the patient should be referred for follow-up of possible hypertension and blood pressure management (321).
Initiating treatment for asymptomatic hypertension in the ED is not necessary when patients have follow-up (322).
Patients with a single elevated blood pressure reading may require further screening for hypertension in the outpatient setting (323).
Pain response to therapy should not be used as the sole diagnostic indicator of the underlying etiology of an acute headache (324).

Patients presenting with acute sudden-onset headache should be considered for an emergent* head computed tomography scan (1). Human immunodeficiency virus (HIV)-positive patients with a new type of headache should be considered for an urgent* neuroimaging study (2). Patients who are older than 50 years presenting with new type of headache without abnormal findings in a neurologic examination should be considered for an urgent neuroimaging study (3).
Adult patients with headache exhibiting signs of increased intracranial pressure including papilledema , absent venous pulsations on funduscopic examination , altered mental status , or focal neurologic deficits should undergo a neuroimaging study before having an LP (4). In the absence of findings suggestive of increased intracranial pressure , an LP can be performed without obtaining a neuroimaging study (5).
Interpretation of Serum Human Chorionic Gonadotropin (hCG) Levels: Arrange follow-up for patients with a nondiagnostic transvaginal ultrasound and a serum hCG level above 2,000 mIU/mL because they have an increased likelihood of ectopic pregnancy (6).
Methotrexate in Ectopic Pregnancy:Because the symptoms associated with gastrointestinal side effects of methotrexate therapy may mimic an acute ectopic rupture , rule out ectopic rupture resulting from treatment failure before attributing gastrointestinal symptoms to methotrexate toxicity (7).
Interpretation of Serum Human Chorionic Gonadotropin (hCG) Levels: Consider transvaginal ultrasound because it may detect ectopic pregnancy when the serum hCG level is below 1,000 mIU/mL (8).
Recent food intake is not a contraindication for administering procedural sedation and analgesia , but should be considered in choosing the timing and target level of sedation (9).
Consider capnometry to provide additional information regarding early identification of hypoventilation (10).
Physicians should fully explain diagnosis , prognosis , and all treatment options to each patient (11).
Discussions should occur with the patient or legal agent about life expectancy and quality of life (12).
For patients requiring dialysis , but who have an uncertain prognosis or for whom a consensus cannot be reached about providing dialysis , nephrologists should consider offering a time-limited trial of dialysis (13).
Modifying Factors: Clinicians should assess the patient with diffuse AOE for factors that modify management (nonintact tympanic membrane , tympanostomy tube , diabetes , immunocompromised state , prior radiotherapy) (14).
Clinicians should inform patients how to administer topical drops (15). When the ear canal is obstructed , delivery of topical preparations should be enhanced by aural toilet , placement of a wick , or both (16).
Topical Therapy: The choice of topical antimicrobial for initial therapy of diffuse AOE should be based upon efficacy , low incidence of adverse events , likelihood of adherence to therapy , and cost (17).
The time to normalization of base deficit, lactate, and pHi is predictive of survival (18).
Measurements of tissue (subcutaneous or muscle) oxygen and/or carbon dioxide levels may identify patients who require additional resuscitation and are at risk for multiple organ dysfunction syndrome and death (19).
Persistently high base deficit or low pHi (or worsening of these parameters) may be an early indicator of complications (eg , ongoing hemorrhage or abdominal compartment syndrome) (20).
All adults and adolescents with chronic kidney disease (CKD) should be evaluated for dyslipidemias (21).
Nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen may be used as adjuncts to opioids in selected patients (22).
Propofol is the preferred sedative when rapid awakening (eg , for neurologic assessment or extubation) is important (23).
Fentanyl is preferred for a rapid onset of analgesia in acutely distressed patients (24).
Disseminated Infection (Extrapulmonary): Nonmeningeal:Amphotericin B is recommended for alternative therapy , especially if lesions are appearing to worsen rapidly and are in particularly critical locations , such as the vertebral column (25).
Disseminated Infection (Extrapulmonary): Nonmeningeal: Initial therapy is usually initiated with oral azole antifungal agents, most commonly fluconazole or itraconazole (26).
Meningitis:Patients who respond to azole therapy should continue this treatment indefinitely (27).
Clinicians should refer patients who require treatment with multiple psychotropic medications and/or are using illicit substances for psychiatric consultation because of the risk of drug-drug interactions and toxicity (28).
Clinicians should refer patients with HAD who present with accompanying depression , mania , psychosis , behavioral disturbance , or substance use for psychiatric consultation to assist in psychopharmacologic treatment and management (29).
Clinicians should exclude other treatable , reversible causes of change in mental status before a diagnosis of HIV-associated dementia (HAD) can be made (30).
Offer screening with FOBT every year combined with flexible sigmoidoscopy every 5 years (31). When both tests are performed , the FOBT should be done first (32).
Screening People at Increased Risk People with a first-degree relative with colon cancer or adenomatous polyp diagnosed at age >60 years or 2 second-degree relatives with colorectal cancer should be advised to be screened as average risk persons , but beginning at age 40 years (33).
Surveillance with colonoscopy should be considered for patients who are at increased risk because they have been treated for colorectal cancer , have an adenomatous polyp diagnosed , or have a disease that predisposes them to colorectal cancer , such as inflammatory bowel disease (34).

Schools should be considered appropriate sites for the availability of condoms , because they contain large adolescent populations and may potentially provide a comprehensive array of related educational and health care resources (1).
Research is encouraged to identify methods to increase correct and consistent condom use by sexually active adolescents and to evaluate effectiveness of strategies to promote condom use, including condom education and availability programs in schools (2).
An intravenous bolus followed by continuous-infusion proton-pump inhibitor is effective in decreasing rebleeding in patients who have undergone successful endoscopic therapy (3).
The placement of clips is a promising endoscopic hemostatic therapy for high-risk stigmata (4).
Clinical (nonendoscopic) stratification of patients into low- and high-risk categories for rebleeding and mortality is important for proper management (5). Available prognostic scales may be used to assist in decision-making (6). Early stratification of patients into low- and high-risk categories for rebleeding and mortality, based on clinical and endoscopic criteria, is important for proper management (7). Available prognostic scales may be used to assist in decision making (8).
In patients with immune deficiency, the initial diagnostic algorithm for patients with acute, subacute, and chronic cough is the same as that for immunocompetent persons, taking into account an expanded list of differential diagnoses that considers the type and severity of immune defect and geographic factors (9).
In human immunodeficiency (HIV)-infected patients , CD4+ lymphocyte counts should be used in constructing the list of differential diagnostic possibilities potentially causing cough (10).
In patients with chronic bronchitis , agents that have been shown to alter mucus characteristics are not recommended for cough suppression (11).
In patients with acute cough due to the common cold , preparations containing zinc are not recommended (12).
In patients with cough due to URI , peripheral cough suppressants have limited efficacy and are not recommended for this use (13).
Follow-up:For patients at lower risk of recurrence (stages I and Ia) or those with co-morbidities impairing future surgery , only visits yearly or when symptoms occur are recommended (14).
Staging: CT or MRI of the pelvis should be done to assess mesorectal margin status (15).
Staging: If T and N category determinations will drive decisions on the use of neoadjuvant therapy , transrectal ultrasound or MRI with endorectal coil is recommended (16). Operator skill is more likely to influence the accuracy of transrectal ultrasound versus MRI with endorectal coil (17). It is likely that advances in technology will demonstrate similar staging accuracy for routine MRI versus MRI with endorectal coil (18).
Review assessment data together with the woman and identify the outcomes important to the woman and amenable to nursing intervention (19).
Incorporate screening questions into a self-assessment that is routinely collected during intake (20).
Ideally , all women should be screened for CPPD on a routine basis (21).
Step 1: Is the patient dehydrated or does the patient have a fluid/electrolyte imbalance? Consider seriously the presence of a fluid/electrolyte imbalance whenever a patient experiences new symptoms or a decline of an existing condition that cannot be readily attributed to another cause (22).
Step 6: Are the causes and consequences of the patient's dehydration or fluid/electrolyte imbalance to be treated? If it is decided to treat the causes of the patient's dehydration or fluid/electrolyte imbalance or to intervene to correct or prevent a fluid deficit or electrolyte imbalance, proceed to Step 7.If the cause of the patient's dehydration is not clear, continue to look for that cause while providing appropriate support and symptomatic management. If it is decided not to treat or intervene because the patient has a terminal or end-stage condition or because the patient or family has requested no intervention, or for any other valid clinical reason, document the reasons for this decision in the patient's medical record (23).

Step 2 Is the patient at risk for dehydration or fluid/electrolyte imbalance? If the patient is not currently dehydrated and has either no fluid/electrolyte imbalance or a mild fluid/electrolyte imbalance , it is important to identify the risk for development or progression of these conditions (1).
The recommended interval between oral health reviews should be determined specifically for each patient and tailored to meet his or her needs , on the basis of an assessment of disease levels and risk of or from dental disease (2).
This assessment should integrate the evidence presented in this guideline with the clinical judgement and expertise of the dental team , and should be discussed with the patient (3).
The longest interval between oral health reviews for patients younger than 18 years should be 12 months (4).
Provide or refer for psychotherapy (5).
Conduct a comprehensive assessment of the social factors specific to spinal cord injury (6).
Use established diagnostic criteria to diagnose depression (7).
Recommendation:As the child's clinical course improves, continuous measurement of SpO2 is not routinely needed (8).
Recommendation: Hand decontamination is the most important step in preventing nosocomial spread of respiratory syncytial virus (RSV) (9). Hands should be decontaminated before and after direct contact with patients , after contact with inanimate objects in the direct vicinity of the patient , and after removing gloves (10).
Recommendation: Alcohol-based rubs are preferred for hand decontamination (11). An alternative is hand-washing with antimicrobial soap (12).
Healthcare professionals should have an increased awareness of the possibility of the presence of otitis media with effusion in asymptomatic children (13).
Parents of children with otitis media with effusion should be advised to refrain from smoking (14).
Children with otitis media with effusion should not be treated with antibiotics (15).
Daily calcium supplementation has not been shown to prevent preeclampsia and , therefore , is not recommended (16).
Antihypertensive therapy (with either hydralazine or labetalol) should be used for treatment of diastolic blood pressure levels of 105/110 mm Hg or higher (17).
If analgesia/anesthesia is required , regional or neuraxial analgesia/anesthesia should be used because it is efficacious and safe for intrapartum management of women with severe preeclampsia in the absence of coagulopathy (18).
Stage Ib1 should be distinguished from stage Ib2 carcinoma of the cervix because the distinction predicts nodal involvement and overall survival and m may therefore , affect treatment and outcome (19).
Treatment for pregnant patients with invasive carcinoma of the cervix should be individualized on the basis of evaluation of maternal and fetal risks (20).
Conization of the cervix is considered a clinical examination (21).
Patients with infected wounds require early and careful follow-up observation to ensure that the selected medical and surgical treatment regimens have been appropriate and effective (22).
Aerobic gram-positive cocci (especially Staphylococcus aureus) are the predominant pathogens in diabetic foot infections (23).
Studies have not adequately defined the role of most adjunctive therapies for diabetic foot infections , but systematic reviews suggest that granulocyte colony-stimulating factors and systemic hyperbaric oxygen therapy may help prevent amputations (24). These treatments may be useful for severe infections or for those that have not adequately responded to therapy , despite correcting for all amenable local and systemic adverse factors (25).
Diagnosis of Primary TumorIn patients with a central lesion who present with or without hemoptysis, sputum cytology (at least three specimens) is a reasonable first step (in centers with a formal program directed at the acquisition, handling, and interpretation of sputum samples) in the diagnostic workup (26).
Diagnosis of Primary Tumor Therefore, a nonspecific result on bronchoscopy of a peripheral lesion that is suspicious for lung cancer requires further testing to definitively rule out cancer (27).
Clinicians should repeat CD4 or viral load results that are inconsistent with the clinical presentation before management decisions are made (28).
Clinicians should maintain a high level of suspicion for acute HIV infection in all patients presenting with a compatible clinical syndrome (29). When acute retroviral syndrome is suspected , a plasma HIV RNA assay should be used in conjunction with HIV-1 antibody test to diagnose acute or primary HIV infection (30).
An individual who tests negative 3 months after exposure but continues to engage in risky behavior should receive counseling to reduce his/her personal risk and the potential transmission to others (31). Such an individual should be offered repeat testing no more than every 3 months as long as risky behavior continues (32).
Because much of the risk of developing type 2 diabetes is attributable to obesity , maintenance of a healthy body weight is strongly recommended as a means of preventing this disease (33). The relationship between glycemic index and glycemic load and the development of type 2 diabetes remains unclear at this time (34).
Low-carbohydrate diets are not recommended in the management of diabetes (35). Although dietary carbohydrate is the major contributor to postprandial glucose concentration, it is an important source of energy, water-soluble vitamins and minerals, and fiber (36). Thus, in agreement with the National Academy of Sciences-Food and Nutrition Board, a recommended range of carbohydrate intake is 45-65% of total calories (37). In addition, because the brain and central nervous system have an absolute requirement for glucose as an energy source, restricting total carbohydrate to <130 grams/day is not recommended.
Regulation of blood glucose to achieve near-normal levels is a primary goal in the management of diabetes, and, thus, dietary techniques that limit hyperglycemia following a meal are likely important in limiting the complications of diabetes (38).
The Discharge Planning Process: Discuss symptom management (39).
The Discharge Planning Process: Clarify activity level and ability, with a focus on safety and mobility (40).
Surveillance interventions (potential areas to address): Ensure adequate functional status before discharge or refer for appropriate home care needs (41).
Prompt investigation of the scene at which the infant was found lifeless or unresponsive and careful interviews of household members by knowledgeable individuals with the legal authority and mandate to conduct such investigations (42).
Accurate history taking by emergency responders and medical personnel at the time of death and immediate transmission of this historical information to the medical examiner or coroner (43).
Appropriate consultations with available medical specialists (eg, pediatrician, pediatric pathologist, pediatric radiologist, and/or pediatric neuropathologist) by medical examiners and coroners (44).
Women should be advised that pregnancies have been reported in COC users taking non-liver enzyme-inducing antibiotics , but the evidence does not generally support reduced COC efficacy and causation (45).
Clinicians giving women information on contraceptive options should enquire about current and previous drug use; prescription , nonprescription and herbal drug use; and specifically about use of drugs which induce liver enzymes and non-liver enzyme-inducing antibiotics (46).
A COC user taking a short course (less than 3 weeks) of non-liver enzyme-inducing antibiotics should be advised to use additional contraceptive protection , such as condoms , during the treatment and for 7 days after the antibiotic has been stopped (47). If fewer than seven active pills are left in the pack after antibiotics have stopped , she should omit the pill-free interval (or discard any inactive pills) (48).
Clinicians should monitor human immunodeficiency virus (HIV)-infected substance users receiving concurrent methadone and ARV therapy for symptoms of withdrawal and/or excess sedation when ARV therapy is initiated or changed (49).
Clinicians should assess adherence and be alert for signs of hepatotoxicity in HIV-infected patients receiving HAART who are concurrently using recreational drugs (50).
Each parenteral nutrition formulation compounded should be inspected for signs of gross particulate contamination , discoloration , particulate formation , and phase separation at the time of compounding and before administration (51).
EN patients who develop diarrhea should be evaluated for antibiotic-associated causes , including Clostridium difficile (52).
In the absence of reliable information concerning compatibility of a specific drug with an SNS formula , the medication should be administered separately from the SNS (53).
Scabies: Recommended Regimen:Permethrin cream (5%) applied to all areas of the body from the neck down and washed off after 8-14 hours (54). OR Ivermectin 200 micrograms/kg orally, repeated in 2 weeks (55).
Follow-Up (56). Patients should be informed that the rash and pruritus of scabies might persist for up to 2 weeks after treatment (57). Symptoms or signs that persist for >2 weeks can be attributed to several factors (58). Treatment failure might be caused by resistance to medication or by faulty application of topical scabicides (59). Patients with crusted scabies might have poor penetration into thick scaly skin and harbor mites in these difficult-to-penetrate layers (60). Particular attention must be given to the fingernails of these patients (61). Reinfection from family members or fomites might occur in the absence of appropriate contact treatment and washing of bedding and clothing (62). Even when treatment is successful and reinfection is avoided , symptoms can persist or worsen as a result of allergic dermatitis (63). Finally , household mites can cause symptoms to persist as a result of crossreactivity between antigens (64). Some specialists recommend re-treatment after 1-2 weeks for patients who are still symptomatic; others recommend re-treatment on ly if if live mites are observed (65).

Patients who do not respond to the recommended treatment should be re-treated with an alternative regimen (1).
Bedding and clothing should be decontaminated (ie , either machine-washed , machine-dried using the hot cycle , or dry cleaned) or removed from body contact for at least 72 hours (2). Fumigation of living areas is unnecessary (3).
Secondary Prevention of Withdrawal Seizures: Benzodiazepines should be used for the secondary prevention of AWS (4).
Secondary Prevention of Withdrawal Seizures: Phenytoin is not recommended for prevention of AWS recurrence (5). The efficacy of other antiepileptics for secondary prevention of AWS is undocumented (6).
Patients with severe alcohol withdrawal symptoms , regardless of seizure occurrence , should be treated pharmacologically (7).
In patients who fail to respond to therapy with methylprednisolone in the dose range used in the randomized , placebo-controlled trials , treatment with higher doses (up to 2 g daily for 5 days) should be considered (8).
A more intense , interdisciplinary rehabilitation programme should be considered after treatment with IV methylprednisolone as evidence from a single trial suggests that this probably further improves recovery (9).
Treatment with IV methylprednisolone (1 g once daily for 3 days with an oral tapering dose) may be considered for treatment of acute optic neuritis (10).
Correlation between IENF Density and Clinical, Neurophysiological, Psychophysical, Autonomic, and Sural Nerve Biopsy Examinations (11).
Studies of Skin Reinnervation: Skin biopsy with quantification of IENF density can be used to assess the regeneration rate of sensory axons in peripheral neuropathies and could represent a potential outcome measure in clinical trials (12).
The Task Force strongly recommends training in an established cutaneous nerve laboratory before performing and processing skin biopsies in the diagnosis of peripheral neuropathies (13). Appropriate normative data from healthy subjects matched for age , gender , ethnicity and anatomical site should be always used (14). Quality control should include all the steps of the procedure , in particular , the aspect of intra- and inter-observer ratings for qualitative assessments and for quantitative analysis of epidermal densities (15).
Prescription or provision of emergency contraception in advance of need can increase availability and use (16).
The following recommendations are based on good and consistent scientific evidence (Level A): The two 0.75-mg doses of the levonorgestrel-only regimen are equally effective if taken 12-24 hours apart.
Treatment with emergency contraception should be initiated as soon as possible after unprotected or inadequately protected intercourse to maximize efficacy (17).
Follow-Up: Failure to improve within 3 days of the initiation of treatment requires reevaluation of both the diagnosis and therapy (18). Swelling and tenderness that persist after completion of antimicrobial therapy should be evaluated comprehensively (19).
Management of Sex Partners: Patients who have acute epididymitis, confirmed or suspected to be caused by N (20). gonorrhoeae or C trachomatis , should be instructed to refer sex partners for evaluation and treatment if their contact with the index patient was within the 60 days preceding onset of the patient's symptoms (21). Patients should be instructed to avoid sexual intercourse until they and their sex partners are cured (ie , until therapy is completed and patient and partners no longer have symptoms) (22).
Treatment: Empiric therapy is indicated before laboratory test results are available (23). As an adjunct to therapy , bed rest , scrotal elevation , and analgesics are recommended until fever and local inflammation have subsided (24). Recommended Regimens: For acute epididymitis most likely caused by gonococcal or chlamydial infection: Ceftriaxone 250 mg IM in a single dose PLUS Doxycycline 100 mg orally twice a day for 10 days For acute epididymitis most likely caused by enteric organisms or for patients allergic to cephalosporins and/or tetracyclines: Ofloxacin 300 mg orally twice a day for 10 days OR Levofloxacin 500 mg orally once daily for 10 days (25).
Several models for the implementation of AED programmes outside the EMS have been described: we have identified three main strategies that have different and to some extent opposite characteristics (26). It is recommended that once the priorities of implementation of an AED programme within the EMS have been achieved , a careful analysis is conducted in order to identify the community model that is most suitable for the specific environment (27). A cost-effectiveness analysis is an essential part of the implementation strategy (28). Every hospital should analyse whether the goal of early defibrillation is achieved and AED implementation can be an important element in improving the in-hospital chain of survival (29). Home programmes are still in a preliminary phase of implementation: families with a genetic predisposition to sudden cardiac death and families with high risk individual(s) who are not scheduled for , or cannot receive , an implantable cardioverter defibrillator (ICD) represent the primary target for pilot projects on home defibrillation (30).
Legislation in Europe is heterogeneous, but where it has relevance to AEDs it either has permitted or is likely to permit their use by nonmedically qualified first responders (31). The lack of data on cost-effectiveness may discourage the support of governments for AED programmes (32). Therefore , this type of economical evaluation should be part of any planned developments (33).
European legislation or recommendation issued by European policy makers and supported by all relevant major health care and scientific societies could promote implementation of this life saving strategy that is strongly supported by scientific evidence (34).
The goal of achieving an effective AED programme within the EMS should become a fundamental objective in every European country (35). Accordingly , it is recommended that an AED and properly trained personnel should be placed in every vehicle that may transport patients at risk of cardiac arrest (36). This should be the first priority for an early access defibrillation programme (37).
Concern about increased new-onset diabetes among patients prescribed a thiazide-type diuretic with a beta-blocker means that this is not recommended as an initial combination for patients at raised risk of developing type II diabetes (38).
Where possible , recommend treatment with drugs taken only once a day (39).
Offer drug therapy to: Patients with persistent high blood pressure of 160/100 mmHg or more Patients at raised cardiovascular risk (10-year risk of coronary heart disease [CHD] >15% or cardiovascular disease [CVD] >20% or existing cardiovascular disease or target organ damage) with persistent blood pressure of more than 140/90 mmHg (40).
Further treatment with efalizumab is not recommended in patients unless their psoriasis has responded adequately at 12 weeks (41).
Etanercept treatment should be discontinued in patients whose psoriasis has not responded adequately at 12 weeks (42). Further treatment cycles are not recommended in these patients (43).
Patients who have begun a course of treatment with efalizumab at the date of publication of this guidance should have the option of continuing to receive treatment until the patients and their clinicians consider it is appropriate to stop (44).
Decontamination of dermal exposures should include routine cleansing with mild soap and water (45). Removal of contact lenses and immediate irrigation with room temperature tap water is recommended for ocular exposures (46). All patients with symptoms of eye injury should be referred for an ophthalmologic exam (47).
A witnessed "taste or lick" only in a child, or an adult who unintentionally drinks and then expectorates all of a concentrated product without swallowing, does not need referral (48).
Referral is not needed if it has been more than 24 hours since a potentially toxic unintentional exposure, the patient has been asymptomatic, and no alcohol was co-ingested (49).
Use the bed only for sleeping (or sex) (50).
Management of medical conditions, psychological disorders and/or symptoms that interfere with sleep such as: depression, pain, hot flashes, anemia, or uremia (51).
For patients with a current diagnosis of a sleep disorder , documentation and continuation of ongoing treatments , such as continuous positive airway pressure (CPAP) , should be maintained and reinforced by patient and family education (52).
Patients with asymptomatic microscopic hematuria who are at risk for urologic disease or primary renal disease should undergo an appropriate evaluation (53). In patients at low risk for disease , some components of the evaluation may be deferred (54).
The initial determination of microscopic hematuria should be based on microscopic examination of the urinary sediment from a freshly voided , clean-catch , midstream urine specimen (55).

The prevalence of asymptomatic microscopic hematuria varies from 0.19 percent to as high as 21 percent.
Additional Laboratory Tests (1). It is recommended that patients with no apparent etiology of HF or no specific clinical features suggesting unusual etiologies undergo additional directed blood and laboratory studies to determine the cause of HF (2).
Exercise testing is not recommended as part of routine evaluation in patients with HF (3).
It is recommended that the following laboratory tests be obtained routinely in patients being evaluated for HF: serum electrolytes , blood urea nitrogen , creatinine , glucose , calcium , magnesium , lipid profile (low-density lipoprotein cholesterol , high-density lipoprotein cholesterol , triglycerides) , complete blood count , serum albumin , liver function tests , urinalysis , and thyroid function (4).
If PTLD has been detected , it is recommended that a contrast enhanced computed tomography (CT) be the modality of choice for further evaluation (5). Chest radiographs, ultrasound, CT, and magnetic resonance imaging (MRI) have been used to detect PTLD (6).
A complete survey that includes the head and neck , chest , abdomen , and pelvis is recommended when PTLD is suspected (7).
Routine use of imaging is not recommended to screen for PTLD (8). Imaging appearance is not specific for PTLD , so it is recommended that histologic evaluation be considered to confirm the diagnosis (9).
It is recommended that a thorough history and physical examination including a detailed neurologic examination and developmental assessment be performed in children presenting with an apparent first , unprovoked seizures (10).
Neuroimaging Routine neuroimaging (magnetic resonance imaging [MRI]/computed tomography [CT]) is not recommended in children with first unprovoked seizures unless the history , physical exam , or neurologic and developmental assessment suggest focality or deterioration/delay , in which case an MRI is the procedure of choice (11).
Electroencephalogram (EEG) It is recommended that patients with an apparent first unprovoked seizure be considered for neurologic evaluation after consultation between the parents and treating physician (12). Neurologic consultation may be more beneficial in situations where the diagnosis is equivocal after a thorough history and physical or in cases of persistent parental anxiety (13).
It is recommended that the child with OME who is at risk for developmental difficulties be aggressively managed as appropriate to his/her condition (14).
It is recommended that all children with OME who have a positive assessment for pain be treated with an appropriate analgesic , though ear pain in OME is not common (15).
It is recommended that the child with OME who is at risk for developmental difficulties be identified early (16).
It is recommended , when 2 or more stimulants have been tried without success , that 2nd tier medications be considered by clinicians if they are familiar with their use (17).
It is recommended that diagnostic information be obtained directly from parents/caregivers in the form of questionnaires and an interview that is structured to elicit information about family structure and dynamics , parenting styles and expectations , and pertinent family educational and psychiatric history (18).
It is recommended that the clinician provide periodic follow-up for the child diagnosed with ADHD (19). This would include monitoring target outcomes and adverse effects by collecting relevant information from parents, teachers, and the child (20).
If systemic hypertension persists on maximal therapy with calcium channel blockers , the following concomitant drug therapy should be considered (21).
It is recommended that amlodipine be initiated at 0,1 mg/kg/day to achieve an arterial blood pressure below the 90th percentile for age (22). Dosing frequency may be adjusted from once daily (Qday) to twice daily (BID) if indicated (23).
It is recommended that systemic arterial blood pressure be maintained within the normal range for age following orthotopic cardiac transplantation (24). Continuous monitoring of arterial blood pressure via an arterial line is recommended during the early postoperative period (25). Blood pressure may be affected by pain (26). Normal values assume adequate pain control (27).
Prevention and Education: It is recommended that immunizations which prevent CAP be kept up-to-date , including: heptavalent conjugated pneumococcal vaccine (28). (PCV7, Prevnar), and annual influenza vaccine for all children 6 to 23 months of age, and children aged >6 months with certain risk factors (including but not limited to asthma, cardiac disease, sickle cell disease, human immunodeficiency virus [HIV] and diabetes) (29).
It is recommended that sputum Gram stain and culture on high quality specimens be considered when managing children with more severe disease (30). Note: A high quality sputum is usually defined by the presence of less than 10 squamous epithelial cells and greater than 25 white blood cells per low power field (31).
It is recommended that the severity of pneumonia be assessed based on overall clinical appearance and behavior , including an assessment of the child's degree of alertness and willingness to accept feedings (32). Subcostal retractions and other evidence of increased work of breathing increase the likelihood of a more severe form of pneumonia (33).
Radiologic Assessment: It is recommended , in children age 6 to 18 years and weight >18 kg [>40 lbs] (for whom surgery is being considered , that an AP pelvis x-ray also be obtained , to evaluate the status of growth plates near the proximal femur as well as to aid in ruling out the presence of femoral neck fracture (34).
Implant/Cast Removal - procedure specific: It is recommended that children treated via flexible intramedullary nailing have arrangements made for implant removal by the end of the third month or the beginning of the fourth month following surgery (35).
Outpatient Management: Quality of Life Assessment: It is recommended that quality of life be assessed periodically using the Pediatric Outcomes Data Collection Instrument (PODCI) conducted during the course of outpatient follow up at: 6 weeks 3 months 6 months 12 months (36).
It is recommended that milrinone be started for any patient with a left atrial pressure >15 mmHg or with signs or symptoms of low cardiac output (37). The recommended loading dose of milrinone is 50 mcg/kg over 30 to 60 minutes, followed by an infusion at 0,375 to 0,75 mcg/kg/min (38).
Treatment Recommendations: It is recommended that milrinone be considered for any patient following arterial switch operation to prevent the occurrence of low cardiac output over the first 24 hours following arterial switch operation (39).
Clinical Assessments:It is recommended that cardiac index be supported to maintain normal to minimally elevated left atrial pressure (5 to 15 mmHg) with evidence of adequate tissue and organ perfusion as defined by physical exam , urine output >1cc/kg/min , and no ongoing metabolic acidosis or lactic acidemia (40).
It is recommended that cefuroxime , cefpodoxime , and cefdinir be second-line therapy for pediatric ABS (41).
It is recommended that , for a child with ABS , physicians explore parental expectations concerning the office visit , parental knowledge regarding respiratory infections , and preventive behavior (42).
It is recommended , for older children with persistent clinical findings after unsuccessful therapy , or for children with clinical evidence of orbital or intracranial complications of ABS , that the decision to perform radiologic studies be made in collaboration with the consulting ophthalmologist or otolaryngologist (43).
Paracentesis: Abdominal paracentesis may be helpful to confirm the presence of intestinal gangrene in infants with NEC (44).
Indications for paracentesis are absence of pneumoperitoneum and one of the following: Portal venous gas (45). Erythema of abdominal wall (46). Fixed, tender abdominal mass (47). Persistently dilated intestinal segment (48). Clinical deterioration (49).
Radiologic Studies: It is recommended that an abdominal radiograph be performed in infants with clinical suspicion of NEC (50). The influences on infant outcome and diagnostic validity of the number of abdominal x-rays, the type of view(s), or the frequency or timing of abdominal radiographs have not been systematically studied (51).
Minimal Enteral Feeding:There is insufficient evidence regarding the role of minimal enteral feedings in preventing NEC (52).
It is recommended that repeated clinical assessment be conducted , as this is the most important aspect of monitoring for deteriorating respiratory status (53).
It is recommended that antihistamines , oral decongestants , and nasal vasoconstrictors not be used for routine therapy (54).
It is recommended that inhalation therapy not be repeated nor continued if there is no improvement in clinical appearance between 15 to 30 minutes after a trial inhalation therapy (55).
Counsel obese and overweight women about the risks of weight cycling--repeated episodes of weight loss and gain--and the benefits of adopting long-term healthy eating habits (56).
For older women, assess blood pressure in both the standing and sitting or supine position (57).
Health Promotion Strategies General Recommendations Stress Management Educate women that feelings of anger and hostility can contribute to higher levels of cholesterol (58).
Consider aspirin therapy (75 to 162 mg) in intermediate-risk women as long as blood pressure is controlled and benefit is likely to outweigh risk of gastrointestinal side effects (59).
Angiotensin-receptor blockers (ARBs) should be used in high-risk women with clinical evidence of heart failure or an ejection fraction who are intolerant to ACE inhibitors (60).

Pharmacotherapy is indicated when blood pressure is >140/90 mm Hg or an even lower blood pressure in the setting of blood pressure related target-organ damage or diabetes (1). Thiazide diuretics should be part of the drug regimen for most patients unless contraindicated (2).
Glutamine may be beneficial in select patients (3). To identify which patients may benefit , each constituent RCT should be reviewed and clinical judgement should be exercised (4).
Gastric residual values and tolerance (5).
Parenteral Nutrition (PN) in preference to Standard Care (6).
Educate caregivers to assist in their ability to care for the wanderer (7).
Assess for neurocognitive deficits and wandering patterns using the Algase Wandering Scale (AWS) (8).
Provide stimulation clues such as pictures and signs (9).
Risk Assessment:Offer genetic testing for family members, as appropriate (10).
Education/Health Promotion:Provide contact information for support groups as requested (11).
Prenatal Diagnosis:If the family mutation is known, preimplantation diagnosis is feasible (12).
Coordinate signing and sending sympathy card (13).
Prior to the death of the resident , the Bereavement Leader should provide information about end-of-life care services , and assistance in contacting these services (14).
Organize and participate in the Memorial Service (15).
Pediatricians should create a variety of ways for children and families to serve as advisors as members of child or family advisory councils , committees , and task forces dealing with operational issues in hospitals , clinics , and office-based practices; as participants in quality improvement initiatives; as educators of staff and professionals in training; and as leaders or coleaders of peer support programs (16).
Pediatricians should promote the active participation of all children in the management and direction of their own health care , beginning at an early age and continuing into adult health care (17).
Health care institutions should design their facilities to promote the philosophy of family-centered care (18).
Complete disability certification forms objectively, accurately and in a timely manner (19).
Determine the presence or absence of a permanent impairment that substantially limits one or more major life activities (20).
Assess fitness for duty and employability by comparing the patient's work capacity to workplace demands (21). Obtain a functional capacity examination if needed (22).
Previously Treated Patients with Intermediate- or High-Risk Chronic Lymphocytic Leukemia Fludarabine is an acceptable treatment option after failure of first-line therapy (23). Choice of treatment should be influenced by previously used regimens and patient preference (24).
It is recommended that patients who have been treated with fludarabine receive irradiated blood products because of the risk of transfusion related graft versus host disease (25).
As first line treatment in patients with intermediate- or high-risk chronic lymphocytic leukemia, fludarabine or conventional chemotherapy (chlorambucil) are acceptable treatment options (26). Fludarabine improves progression-free survival but has a greater risk of toxicity, including specific infections (27).
Recommendation:When providing physical activity advice , primary care practitioners should take into account the individual's needs , preferences , and circumstances (28). They should agree goals with them (29). They should also provide written information about the benefits of activity and the local opportunities to be active (30). They should follow them up at appropriate intervals over a 3- to 6-month period (31).
Recommendation (32). Practitioners , policy makers , and commissioners should only endorse exercise referral schemes to promote physical activity that are part of a properly designed and controlled research study to determine effectiveness (33). Individuals should only be referred to schemes that are part of such a study (34).
Recommendation: Practitioners , policy makers , and commissioners should only endorse pedometers and walking and cycling schemes to promote physical activity that are part of a properly designed and controlled research study to determine effectiveness (35). Measures should include intermediate outcomes such as knowledge , attitude , and skills , as well as measures of physical activity levels (36).
Available evidence does not support a recommendation for or against moderate caloric restriction in obese women with gestational diabetes mellitus (GDM) (37). However , if caloric restriction is used , the diet should be restricted by no more than 33% of calories (38).
The laboratory screening test should consist of a 50-g , 1-hour oral glucose challenge at 24 to 28 weeks of gestation , which may be administered without regard to the time of the last meal (39).
The screening test generally should be performed on venous plasma or serum samples using well-calibrated and well-maintained laboratory instruments (40).
The first line of treatment in primary open angle glaucoma (POAG) is medical therapy and the choice of the drug depends on the target IOP, the safety profile of the drug, patient acceptance, and cost (41).
Surgery is indicated in patients who fail or are unable to comply with medical therapy and may be combined with cataract removal for enhanced visual rehabilitation (42).
The target IOP is an estimate of the mean IOP achieved with treatment that is expected to prevent further optic nerve damage (43). An individualised target IOP range should be set for every glaucoma patient (44).
Patients currently treated in hospital who are potentially suitable for home haemodialysis on clinical grounds , but who have not previously been offered a choice , should be reassessed and informed about their dialysis options (45).
It is recommended that all suitable patients should be offered the choice between home haemodialysis or haemodialysis in a hospital/satellite unit (46).
Patients performing haemodialysis at home and their carers will require initial training and an accessible and responsive support service (47). The support service should offer the possibility of respite hospital/satellite unit dialysis as required (48).
Capecitabine monotherapy is recommended as an option for people with locally advanced or metastatic breast cancer who have not previously received capecitabine in combination therapy and for whom anthracycline and taxane-containing regimens have failed or further anthracycline therapy is contraindicated (49).
In the treatment of locally advanced or metastatic breast cancer , capecitabine in combination with docetaxel is recommended in preference to single-agent docetaxel in people for whom anthracycline-containing regimens are unsuitable or have failed (50). The decision regarding treatment should be made jointly by the individual and the clinician(s) responsible for treatment (51).
The decision should be made after an informed discussion between the clinician(s) and the patient; this discussion should take into account contraindications and the side-effect profile of the agents , alternative treatments for locally advanced or metastatic breast cancer , and the clinical condition and preferences of the individual (52).
Valid consent should be obtained in all cases where the individual has the ability to grant or refuse consent (53). The decision to use ECT should be made jointly by the individual and the clinician(s) responsible for treatment , on the basis of an informed discussion (54). This discussion should be enabled by the provision of full and appropriate information about the general risks associated with ECT and about the risks and potential benefits specific to that individual (55). Consent should be obtained without pressure or coercion , which may occur as a result of the circumstances and clinical setting , and the individual should be reminded of their right to withdraw consent at any point (56). There should be strict adherence to recognised guidelines about consent and the involvement of patient advocates and/or carers to facilitate informed discussion is strongly encouraged (57).
As the longer-term benefits and risks of ECT have not been clearly established , it is not recommended as a maintenance therapy in depressive illness (58).
The effectiveness of glitazone combination therapy should be monitored against treatment targets for glycaemic control (usually in terms of haemoglobin A1c [HbA1c] level) and for other cardiovascular risk factors , including lipid profile (59). The target HbA1c level should be set between 6,5% and 7,5% , depending on other risk factors (60).
For people with type 2 diabetes, the use of a glitazone as second-line therapy added to either metformin or a sulphonylurea--as an alternative to treatment with a combination of metformin and a sulphonylurea--is not recommended except for those who are unable to take metformin and a sulphonylurea in combination because of intolerance or a contraindication to one of the drugs (61). In this instance , the glitazone should replace in the combination the drug that is poorly tolerated or contraindicated (62).
It is recommended that a GP IIb/IIIa inhibitor is considered as an adjunct to PCI for all patients with diabetes undergoing elective PCI , and for those patients undergoing complex procedures (for example , multi-vessel PCI , insertion of multiple stents , vein graft PCI , or PCI for bifurcation lesions); currently only abciximab is licensed as an adjunct to PCI (63). In procedurally uncomplicated, elective PCI, where the risk of adverse sequelae is low , use of a GP IIb/IIIa inhibitor is not recommended unless unexpected immediate complications occur (64).
It is recommended that in determining who is at high risk , clinicians should take into account combinations of risk factors such as: clinical history , including age , previous MI , and previous PCI or CABG; clinical signs , including continuing pain despite initial treatment; and clinical investigations , such as electrocardiogram (ECG) changes (particularly dynamic or unstable patterns indicating myocardial ischaemia) , haemodynamic changes , and raised cardiac troponin levels (65).
Cardiac troponin testing is useful for diagnosing acute coronary syndromes and in risk stratification (66). However, it is recommended that in patients considered to be at high risk, treatment with a small-molecule GP IIb/IIIa inhibitor is initiated as soon as high-risk status is determined even though this may be before the result of a troponin test is known (67).
Hotodynamic therapy (PDT) is recommended for the treatment of wet age-related macular degeneration for individuals who have a confirmed diagnosis of classic with no occult subfoveal choroidal neovascularisation (CNV) (that is , whose lesions are composed of classic CNV with no evidence of an occult component) and best-corrected visual acuity 6/60 or better (68). PDT should be carried out only by retinal specialists with expertise in the use of this technology (69).
The use of PDT in occult CNV associated with wet age-related macular degeneration was not considered because the photosensitising agent (verteporfin) was not licensed for this indication when this appraisal began (70). No recommendation is made with regard to the use of this technology in people with this form of the condition (71).
PDT is not recommended for the treatment of people with predominantly classic subfoveal CNV (that is , 50% or more of the entire area of the lesion is classic CNV but some occult CNV is present) associated with wet age-related macular degeneration , except as part of ongoing or new clinical studies that are designed to generate robust and relevant outcome data , including data on optimum treatment regimens , long-term outcomes , quality of life , and costs (72).
Patients who have not responded to one of these hypnotic drugs should not be prescribed any of the others (73).
These are the only circumstances in which the drugs with the higher acquisition costs are recommended (74).
Zanamivir and oseltamivir are not recommended for the treatment of influenza in children or adults unless they are considered to be at risk (75).
At-risk adults and children are defined for the purpose of this guidance as those who are in at least one of the following groups (76). People who: Have chronic respiratory disease (including asthma and chronic obstructive pulmonary disease) (77). Have significant cardiovascular disease (excluding people with hypertension only) (78). Have chronic renal disease (79). Are immunocompromised (80). Have diabetes mellitus (81). Are aged 65 years or older (82).
Community-based virological surveillance schemes should be used to indicate when influenza virus is circulating in the community (83). Community-based virological surveillance schemes , such as those organised by the Royal College of General Practitioners and the Public Health Laboratory Service , should be used to indicate when influenza virus is circulating in the community (84). Such schemes should ensure that the onset of the circulation of influenza virus (A or B) within a defined area is identified as rapidly as possible (85).
Recommend patients with wounds and LEAD seek care guided by a clinical wound expert (86).
Relate wound treatments to adequacy of perfusion status (87).
Prior to treatment, assess causative and contributive factors and significant signs and symptoms to differentiate types of lower-extremity ulcers, which require varying treatment modalities (88).
Refer the patient for further evaluation for suspected infection, positive probe to bone, and radiographic changes demonstrating Charcot osteoarthropathy (89).
Refer high-risk patients to foot care specialists for ongoing preventive care and lifelong surveillance (90).
Ensure adequate offloading of pressure through wound closure (91).
Prevention: Continue preventive measures even when a patient has a pressure ulcer to prevent additional pressure areas from developing (92).
Prevention: Avoid vigorous massage over bony prominences (93).
Perform wound care using topical dressings determined by wound, patient needs, cost, caregiver time, and availability (94).

Assessment of pain in children with juvenile FMS (JFMS) should be developmentally based and should include both child and parent components (1). Include pain history, behavioral observation, physiologic cues, and evaluation of comorbid mood disorders, psychosocial distress, and functional status, including school attendance, for a comprehensive assessment (2).
Provide education for the child and family on the diagnosis of JFMS, interrelationship of symptoms, and management of symptoms (3). Provide education to the child and family on an ongoing basis to increase self-care skills, improve self-efficacy, and enhance understanding of the interrelationships between pain, mood, stress, exercise, and the role of factors concerning the parental and family environment (4). Include background information regarding the prevalence of pain in children (5).
Encourage people with FMS to perform muscle-strengthening exercise two times per week (6).
Patients should be instructed in the correct use of glucose meters , including quality control (7). Comparison between SMBG and concurrent laboratory glucose analysis should be performed at regular intervals to evaluate the accuracy of patient results (8).
At a minimum , the end-points should be glycated hemoglobin (GHb) and frequency of hypoglycemic episodes (9). Ideally , outcomes (eg , long-term complications and hypoglycemia) should also be examined (10).
Intraoperatively , the endoscopic general surgeon should participate in positioning the patient and selecting the proper locations of the trocars (11). The endoscopic general surgeon is not only responsible for safe entry into either the peritoneum or the retroperitoneum but also must participate in safe dissection to expose the proper spinal anatomy (12). He/she should be immediately available throughout the entire operative procedure (13). At the conclusion of the procedure, the endoscopic surgeon is responsible for safely exiting the peritoneum or retroperitoneum and for closure of trocar sites (14). The endoscopic surgeon must be capable of recognizing and managing intraoperative laparoscopic complications (15).
Each co-surgeon must adequately document his/her respective preoperative , intraoperative , and postoperative participation according to Joint Commission on Accreditation of Healthcare Organizations (JCAHO) standards (16).
Special attention should be directed towards suitability of the patient for anesthesia and for the proposed endoscopic procedure (17). The endoscopic surgeon should not feel obligated to participate in any procedure that he/she does not feel is in the best interest of the patient (18). Risks and complications unique to the endoscopic access portion of the procedure should be identified and communicated to the patient at this time , as well as the specific roles and responsibilities of the endoscopic general surgeon (19). The endoscopic general surgeon and spine surgeon should each communicate their individual experience in this procedure to the patient (20). This results in a true informed consent (21). Both co-surgeons must be named on the patient consent form (22).
Orotracheal intubation guided by direct laryngoscopy is the emergency tracheal intubation procedure of choice for trauma patients (23).
The laryngeal mask airway and Combitube are alternatives to cricothyrostomy and may be selected when cricothyrostomy expertise is limited (24).
Tracheal Intubation Immediately Following Traumatic Injury Emergency tracheal intubation is needed in trauma patients with the following traits: airway obstruction hypoventilation severe hypoxemia (hypoxemia despite supplemental oxygen) severe cognitive impairment (Glasgow Coma Score [GCS] <8) cardiac arrest severe hemorrhagic shock.
In children with cough , cough suppressants and other over the counter (OTC) cough medicines should not be used as patients , especially young children , may experience significant morbidity and mortality (25).
Children with chronic cough should undergo , as a minimum , a chest radiograph and spirometry (if age appropriate) (26).
In children with nonspecific cough and risk factors for asthma , a short trial (ie , 2 to 4 weeks) of beclomethasone , 400 micrograms/day , or the equivalent dosage with budesonide may be warranted (27).
Children and adolescents with newly suspected and/or recurrent malignancy should be referred to a pediatric cancer center for prompt and accurate diagnosis and management (28).
Multidisciplinary team members should have pediatric expertise within their specialty area (29).
Glucose-6-phosphate dehydrogenase deficiency predisposes to haematological side effects and should be excluded in predisposed races (30). The side-effect profile of dapsone and sulphonamides is potentially hazardous in the elderly (31). These treatments should be considered only if other treatments are ineffective or contraindicated (32).
The total published experience of intravenous immunoglobulin in BP amounts to five small series that suggest that it is of limited value (33). Used mainly at a dose of 0.4 mg/kg polyvalent immunoglobulin daily for 5 days, either as a sole treatment or with oral prednisolone, it produced some occasional dramatic but unfortunately very transient responses that were too short-lived to be useful.
Erythromycin should be considered for treatment , particularly in children (adult dose 1,000-3,000 mg daily) and perhaps in combination with topical corticosteroids (34). A beneficial effect may be seen within 1 to 3 weeks after commencing treatment (35). Long-term follow up in a specialized clinic is unnecessary for uncomplicated disease that is well controlled clinically using small amounts of a topical corticosteroid , and follow up should be reserved for patients with complicated LS that is unresponsive to treatment and those patients who have persistent disease with history of a previous SCC (36).
Surgery , Laser , Photodynamic Therapy and Cryotherapy: Adult Female Anogenital Lichen Sclerosus: There is no indication for removal of vulval tissue in the management of uncomplicated LS , and surgery should be used exclusively for malignancy and postinflammatory sequelae (37). In one study, nine of 12 patients with severe itch due to vulval LS unresponsive to topical treatment responded to cryotherapy, 50% for 3 years (38).
An ultrapotent topical corticosteroid is the first-line treatment for LS in either sex at any site, but there are no randomized controlled trials comparing corticosteroid potency, frequency of application, and duration of treatment (39).
Repeated courses of intravenous immunoglobulin could be considered as an adjuvant , maintenance agent in patients with recalcitrant disease who have failed more conventional therapies (40). In view of reports of a rapid action in some cases , it could be used to help induce remission in patients with severe PV while slower-acting drugs take effect (41).
Tetracyclines with or without nicotinamide could be considered as adjuvant treatment , perhaps in milder cases of PV (42).
In situ lumbar PLF is recommended as a treatment option in addition to decompression in patients with lumbar stenosis without deformity in whom there is evidence of spinal instability (43).
In situ posterolateral lumbar fusion is not recommended as a treatment option in patients with lumbar stenosis in whom there is no evidence of preexisting spinal instability or likely iatrogenic instability due to facetectomy (44).
The addition of pedicle screw instrumentation is not recommended in conjunction with PLF following decompression for lumbar stenosis in patients without spinal deformity or instability (45).
The use of lumbar brace therapy as a preoperative diagnostic tool to predict outcome following lumbar fusion surgery is not recommended (46).
The use of transpedicular external fixation as a tool to predict outcome following lumbar fusion surgery is not recommended (47).
Lumbar braces are recommended as a means of decreasing the number of sick days lost due to low-back pain among workers with a previous lumbar injury (48). They are not recommended as a means of decreasing low-back pain in the general working population (49).
Lateral flexion and extension radiography is recommended as an adjunct to determine the presence of lumbar fusion postoperatively (50). The lack of motion between vertebrae, in the absence of rigid instrumentation, is highly suggestive of successful fusion (51).
Static lumbar radiographs are not recommended as a stand-alone means to assess fusion status following lumbar arthrodesis surgery (52).
Technetium- 99 bone scanning is not recommended as a means to assess lumbar fusion (53).
It is recommended that patients in whom discography is positive but in whom MR imaging evidence of disc degeneration is absent not be considered candidates for operative intervention (54).
It is recommended that discography be reserved for use in patients with equivocal MR imaging findings , especially at levels adjacent to clearly pathological levels (55).
Health practitioners should provide workers at risk of occupational asthma with health surveillance at least annually and more frequently in the first two years of exposure (56). SIGN 2+ Sensitisation and occupational asthma are most likely to develop in the first years of exposure for workers exposed to enzymes, complex platinum salts, isocyanates, and laboratory animal allergens (57).
Employers and their health and safety personnel should ensure that when respiratory protective equipment is worn , the appropriate type is used and maintained , fit testing is performed and workers understand how to wear , remove , and replace their respiratory protective equipment (58).
Use with caution in patients at risk for development of prolonged QT syndrome: congestive heart failure (CHF), bradycardia, cardiac hypertrophy, hypokalemia/magnesemia, on other drugs known to prolong the QT interval (59).
Anesthetic agents such as propofol and sedation adjuncts such as droperidol, promethazine, and diphenhydramine are useful in certain patients undergoing endoscopic procedures (60). While propofol provides faster onset and deeper sedation than standard benzodiazepines and narcotics, as well as faster recovery, clinically important benefits have not been consistently demonstrated in average-risk patients undergoing standard upper and lower endoscopy (61).
Trained personnel dedicated to the continuous and uninterrupted monitoring of the patients physiologic parameters and administration of propofol (62).
Key Recommendations by Diagnosis: Candidemia and Acute Hematogenously Disseminated Candidiasis:For clinically stable patients who have not recently received azole therapy, fluconazole (>6 mg/kg per day; ie, >400 mg/day for a 70-kg patient) is another appropriate choice (63).
Key Recommendations by Diagnosis: Candidal Endocarditis , Pericarditis , Suppurative Phlebitis , and Myocarditis: Both native valve and prosthetic valve infection should be managed with surgical replacement of the infected valve (64). Medical therapy with amphotericin B with or without flucytosine at maximal tolerated doses has most often been used (65).
Key Recommendations by Diagnosis:Disseminated Cutaneous Neonatal Candidiasis: Prematurely born neonates , neonates with low birth weight , or infants with prolonged rupture of membranes who demonstrate the clinical findings associated with disseminated neonatal cutaneous candidiasis should be considered for systemic therapy (66). Amphotericin B deoxycholate (0,5-1 mg/kg per day, for a total dose of 10-25 mg/kg) is generally used (67).
Where myeloma and AL amyloidosis co-exist , choice of treatment for myeloma should take into account the extent of organ involvement with amyloid and the potential toxicities of individual treatments (68).

Midodrine is the most effective drug for orthostatic hypotension in patients with amyloidosis , but can cause supine hypertension (1).
Solitary extramedullary plasmacytoma should be treated by radical radiotherapy encompassing the primary tumour with a margin of at least 2 cm (2).
Reconstruction of the anterior column may be beneficial (3).
Alkylating-agent based therapy is appropriate for the initial and subsequent treatment of Waldenstrom's Macroglobulinaemia (4). Purine analogues are appropriate for the initial and subsequent treatment of Waldenstrom's Macroglobulinaemia (5). There is no consensus on the duration of treatment with cladribine or fludarabine, or on which purine analogue is superior (6). Fludarabine is more active than cyclophosphamide, doxorubicin and prednisolone (CAP) as salvage therapy (7). 1-2 procedures, exchanging 1-1 calculated plasma volumes is advised for the treatment of hyperviscosity syndrome (HVS) in Waldenstrm's macroglobulinaemia (WM) (8). In patients who are drug resistant this may be indicated as long term management (9).
Esophageal pH recording is possibly indicated to detect refractory reflux in patients with chest pain after cardiac evaluation using a symptom reflux association scheme , preferably the symptom association probability calculation (pH study done after a trial of proton pump inhibitor therapy for at least 4 weeks) (10).
Esophageal pH recording is possibly indicated to document concomitant gastroesophageal reflux disease in an adult onset , nonallergic asthmatic suspected of having reflux-induced asthma (pH study done after withholding antisecretory drugs for > 1 week) (11). Note: a positive test does not prove causality (12).
Esophageal pH recording is indicated to evaluate patients with either normal or equivocal endoscopic findings and reflux symptoms that are refractory to proton pump inhibitor therapy (pH study done after withholding antisecretory drug regimen for >= 1 week if the study is done to confirm excessive acid exposure or while taking the antisecretory drug regimen if symptom-reflux correlation is to be scored) (13).
School personnel involved in detection of head lice infestation should be appropriately trained (14). The importance and difficulty of correctly diagnosing an active head lice infestation should be acknowledged (15).
Head lice screening programs have not been proven to have a significant effect on the incidence of head lice in the school setting over time and are not cost-effective (16). Parent education programs may be helpful in the management of head lice in the school setting (17).
None of the currently available pediculicides are 100% ovicidal and resistance has been reported with lindane, pyrethrins, and permethrin (18). Treatment failure does not equate with resistance, and most instances of such failure represent misdiagnosis/misidentification or noncompliance with the treatment regimen (19).
Perform a renal ultrasound (or repeat the ultrasound if it was done prenatally) (20). If the patient is found to have an abnormality of the urinary tract, continue monitoring for urinary tract infections and renal function (21).
Continue to evaluate the child's renal status (urinalysis and culture, as indicated) if a renal anomaly is present (22).
Check the adolescent annually for scoliosis and kyphosis (23).
For patients with systolic dysfunction (ejection fraction [EF] <40%) who have no contraindications:Aldosterone antagonist (low dose) for patients with rest dyspnea or with a history of rest dyspnea or for symptomatic patients who have suffered a recent myocardial infarction.
Bi-ventricular pacemakers considered for patients requiring defibrillators who have symptomatic HF and QRS durations > 120 msec (24).
Implantable defibrillators considered for prophylaxis against sudden cardiac death in patients with EF < 35%.
Evaluate the patient for the presence of risk factors for heart failure (25).
Monitor the patient's condition and response to treatment (26).
Treat the chronic underlying cardiac condition (27).
Routine post-vaccination antibody measurement is not recommended because of the generally high efficacy of the vaccine (28).
Clinicians should administer HAV vaccination early in the course of human immunodeficiency virus (HIV) infection (29). If a patient's CD4 count is <300 cells/mm3 or the patient has symptomatic HIV disease, it is preferable to defer vaccination until several months after initiation of antiretroviral (ARV) therapy in an attempt to maximize the antibody response to the vaccine.
The full series should be given (initial dose and a second dose 6 to 12 months later) to ensure maximal antibody response (30).
Treatment of Hepatitis C Infection: Treatment for HCV should be considered for all patients co-infected with HIV and HCV (31).
Sexual Assault Forensic Examiner (SAFE) who is trained to perform pediatric examinations should be included on the team whenever possible to assist in the medical examination , coordination of care , and discussions about treatment regimen (32). A rape crisis counselor and/or child advocacy team should be involved in all cases of sexual assault to assist the child and the family in dealing with the trauma and to assist with referrals (33).
Non-occupational PEP should not be prescribed when there is negligible or low risk of HIV transmission (34).
Recommending nPEP For Sexual Assault Survivors: Starter packs of medication should be available on-site for rapid initiation of nPEP following sexual assault (35). Arrangements should be made to ensure that the patient receives a continued supply of medication and is referred to an HIV specialist (36).
If thrombocytopenia is accompanied by other cytopenias or splenomegaly and is mild (>50 ,000 cells/mm3) , 000 cells/mm3) , hypersplenism caused by infectious causes or coincident liver disease should be suspected (37).
If endogenous erythropoietin levels are <500 mUnits/mL, erythropoietin therapy (50-200 iu/kg/dose 3 times/week) should be administered to reduce the need for transfusion. Supplemental oral iron (3-6 mg/kg/day of elemental iron) and folate (1 mg/day) should be administered when erythropoietin is initiated (38).
Antiretroviral therapy should be the primary treatment of HIV-associated thrombocytopenic purpura unless 1) it has been previously demonstrated to be ineffective , 2) the count needs to be increased within 2 weeks, or 3) there are other reasons not to initiate it, such as refusal, intolerance, or limited antiretroviral susceptibility (39). Treatment of asymptomatic, mild to moderate, HIV-associated thrombocytopenia is usually not necessary (40).
This guidance applies to the use of the aromatase inhibitors anastrozole, exemestane, and letrozole, within the marketing authorisations for each drug at the time of this appraisal, for the treatment of early oestrogen-receptor-positive breast cancer; that is: Anastrozole for primary adjuvant therapy Exemestane for adjuvant therapy following 2?3 years of adjuvant tamoxifen therapy Letrozole for primary adjuvant therapy and extended adjuvant therapy following standard tamoxifen therapy (41). The aromatase inhibitors anastrozole , exemestane , and letrozole , within their licensed indications , are recommended as options for the adjuvant treatment of early oestrogen-receptor-positive invasive breast cancer in postmenopausal women (42).
The choice of treatment should be made after discussion between the responsible clinician and the woman about the risks and benefits of each option (43). Factors to consider when making the choice include whether the woman has received tamoxifen before, the licensed indications and side-effect profiles of the individual drugs and, in particular, the assessed risk of recurrence (44).
It is recommended that , in women with a previous VTE , with or without an underlying heritable thrombophilia , oral HRT should usually be avoided in view of the relatively high risk of recurrent VTE (45).
HRT should be considered a risk factor for VTE when assessing women preoperatively (46). However, HRT does not require to be routinely stopped prior to surgery provided that appropriate thromboprophylaxis, such as low-dose or low-molecular-weight heparin, with or without thromboembolic deterrent stockings, is used (47).
Prior to commencing HRT , a personal history and a family history assessing the presence of venous thromboembolism (VTE) in a first- or second-degree relative should be obtained (48).
Consider referral to a program that provides guidance on nutrition, physical activity, and psychosocial concerns (49).
Weight loss surgery should be considered only for patients in whom other methods of treatment have failed and who have clinically severe obesity (ie , BMI >40 or BMI >35 with life-threatening comorbid conditions (50).
Assess current eating, exercise behaviors, history of weight loss attempts, and psychological factors contributing to weight gain (51).
Pediatricians can work locally , nationally , and internationally to help change cultural norms conducive to eating disorders and proactively to change media messages (52).
Pediatricians should be familiar with the screening and counseling guidelines for disordered eating and other related behaviors (53).
Mycophenolate mofetil is recommended for adults as an option as part of an immunosuppressive regimen only: Where there is proven intolerance to calcineurin inhibitors , particularly nephrotoxicity leading to risk of chronic allograft dysfunction , or In situations where there is a very high risk of nephrotoxicity necessitating minimisation or avoidance of a calcineurin inhibitor (54).
Basiliximab or daclizumab , used as part of a calcineurin-inhibitor-based immunosuppressive regimen , are recommended as options for induction therapy in the prophylaxis of acute organ rejection in adults undergoing renal transplantation (55). The induction therapy (basiliximab or daclizumab) with the lowest acquisition cost should be used (56).
Tacrolimus is an alternative to ciclosporin when a calcineurin inhibitor is indicated as part of an initial or a maintenance immunosuppressive regimen in renal transplantation for adults (57). The initial choice of tacrolimus or ciclosporin should be based on the relative importance of their side-effect profiles for individual people (58).
Patients should have adequate , accurate information regarding factors that influence HIV transmission and methods for reducing the risk for transmission to others , emphasizing that the most effective methods for preventing transmission are those that protect noninfected persons against exposure to HIV (eg , sexual abstinence; consistent and correct use of condoms made of latex , polyurethane or other synthetic materials; and sex with only a partner of the same HIV serostatus) (59). HIV-infected patients who engage in high-risk sexual practices (ie , capable of resulting in HIV transmission) with persons of unknown or negative HIV serostatus should be counseled to use condoms consistently and correctly (60).

[1] http://www.acetic.fr

[2] http://www.textworld.com/scp/

[3] Gersende Georg, Marie-Christine Jaulent. A Document Engineering Environment for Clinical Guidelines. In: Peter R. King & Steven J. Simske. DocEng'07 - Proceedings of the 2007 ACM Symposium on Document Engineering. 28-31 August 2007, Winnipeg, Manitoba, Canada. ACM Press, New York NY, USA. 2007;:69-78.